[X] Close
You are about to erase all the values you have customized, search history, page format, etc.
Click here to RESET all values       Click here to GO BACK without resetting any value
Items 1 to 100 of about 3925
1. Usui S, Hiranuma S, Ichikawa T, Maeda M, Kudo SE, Iwai T: Preoperative imaging of surrounding arteries by three-dimensional CT: is it useful for laparoscopic gastrectomy? Surg Laparosc Endosc Percutan Tech; 2005 Apr;15(2):61-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • One of the difficulties in laparoscopic gastrectomy is the identification of the feeding artery of the stomach.
  • Recently, 3-dimensional computed tomographic angiography has enabled the noninvasive visualization of arteries surrounding the stomach.
  • Preoperative 3-dimensional computed tomographic angiography may facilitate laparoscopic gastrectomy by obtaining a road map of the arteries of the stomach.
  • Twenty-nine cases of gastric cancer were evaluated using 3-dimensional computed tomographic angiography before surgery.
  • Three-dimensional computed tomographic angiography showed the left gastric artery in 29 patients (100%), the right gastroepiploic artery in 29 patients (100%), the right gastric artery in 24 patients (82.8%), and the left gastroepiploic artery in 21 patients (72.4%).
  • The aberrant hepatic artery was detected in 6 patients, and the variant of the right gastric artery and the variant of the left gastric artery were detected in 5 cases and 1 case, respectively.
  • [MeSH-major] Adenocarcinoma / surgery. Angiography. Gastrectomy / methods. Imaging, Three-Dimensional. Laparoscopy / methods. Preoperative Care / methods. Stomach Neoplasms / surgery. Tomography, X-Ray Computed

  • MedlinePlus Health Information. consumer health - CT Scans.
  • MedlinePlus Health Information. consumer health - Stomach Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15821615.001).
  • [ISSN] 1530-4515
  • [Journal-full-title] Surgical laparoscopy, endoscopy & percutaneous techniques
  • [ISO-abbreviation] Surg Laparosc Endosc Percutan Tech
  • [Language] eng
  • [Publication-type] Evaluation Studies; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  •  go-up   go-down


2. Pantidou A, Kiziridou A, Antoniadis T, Tsilikas C, Destouni C: Mediastinum thymoma diagnosed by FNA and ThinPrep technique: a case report. Diagn Cytopathol; 2006 Jan;34(1):37-40
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • This is an interesting case of thymoma diagnosed by fine-needle aspiration biopsy (FNA) and ThinPrep technique, in a 54-year-old female patient with a history of gastric adenocarcinoma.
  • The tumor was excised and the histopathological examination supported the cytological diagnosis.
  • Thymomas commonly constitute a problem in differential diagnosis of mediastinum masses.
  • [MeSH-major] Biopsy, Fine-Needle. Mediastinal Neoplasms / diagnosis. Thymoma / diagnosis. Thymoma / pathology
  • [MeSH-minor] Adenocarcinoma / pathology. Female. Histocytological Preparation Techniques. Humans. Middle Aged. Neoplasms, Second Primary / diagnosis. Stomach Neoplasms / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16355373.001).
  • [ISSN] 8755-1039
  • [Journal-full-title] Diagnostic cytopathology
  • [ISO-abbreviation] Diagn. Cytopathol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


3. Tanabe H, Hara H, Ohtubo C, Miyokawa N, Sano H: [Disappearance of gastric adenocarcinoma in hyperplastic polyp after eradication of Heliobacter pylori. Report of a case]. Nihon Shokakibyo Gakkai Zasshi; 2005 May;102(5):559-63
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Disappearance of gastric adenocarcinoma in hyperplastic polyp after eradication of Heliobacter pylori. Report of a case].
  • [MeSH-major] Adenocarcinoma / microbiology. Anti-Bacterial Agents / administration & dosage. Helicobacter Infections / drug therapy. Helicobacter pylori. Polyps / microbiology. Stomach Neoplasms / microbiology

  • MedlinePlus Health Information. consumer health - Antibiotics.
  • MedlinePlus Health Information. consumer health - Helicobacter Pylori Infections.
  • MedlinePlus Health Information. consumer health - Stomach Cancer.
  • Hazardous Substances Data Bank. OMEPRAZOLE .
  • Hazardous Substances Data Bank. Clarithromycin .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15920952.001).
  • [ISSN] 0446-6586
  • [Journal-full-title] Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology
  • [ISO-abbreviation] Nihon Shokakibyo Gakkai Zasshi
  • [Language] jpn
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Japan
  • [Chemical-registry-number] 0 / Anti-Bacterial Agents; H1250JIK0A / Clarithromycin; KG60484QX9 / Omeprazole
  •  go-up   go-down


Advertisement
4. Kim JH, Kim SS, Byun SW, Chang YJ, Kim JS, Kim JK, Cho HJ, Lim KW, Jung ES: [Double strand break of DNA in gastric adenoma and adenocarcinoma]. Korean J Gastroenterol; 2010 Jan;55(1):19-25
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Double strand break of DNA in gastric adenoma and adenocarcinoma].
  • The aim of this study was to define the differences in expression of 53BP1 and gamma-H2AX, the markers of DSB, among normal, gastric adenoma, and gastric adenocarcinoma tissues.
  • METHODS: Tissue microarray was made with the tissues taken from 121 patients who underwent gastrectomy for gastric adenocarcinoma, and 51 patients who underwent endoscopic mucosal resection for gastric adenoma.
  • The normal tissues were collected from histologically confirmed tissues with no cellular atypia obtained from the patients with gastric adenocarcinoma.
  • RESULTS: In gastric carcinoma cells, 53BP1 and gamma-H2AX were highly expressed as compared to normal epithelial cells and gastric adenoma (p<0.01).
  • There were no differences in the expression of 53BP1 and gamma-H2AX between normal epithelium and gastric adenoma.
  • The expression of 53BP1 and gamma-H2AX were not significantly different according to the clinicopathologic parameters in the patients with gastric adenocarcinoma.
  • CONCLUSIONS: The DSB in DNA seems to be associated with the development of gastric adenocarcinoma, but does not affect the premalignant adenoma cells.
  • [MeSH-major] Adenocarcinoma / metabolism. Adenoma / metabolism. DNA Breaks, Double-Stranded. Stomach Neoplasms / metabolism

  • MedlinePlus Health Information. consumer health - Stomach Cancer.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20098063.001).
  • [ISSN] 1598-9992
  • [Journal-full-title] The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi
  • [ISO-abbreviation] Korean J Gastroenterol
  • [Language] kor
  • [Publication-type] Journal Article
  • [Publication-country] Korea (South)
  • [Chemical-registry-number] 0 / H2AFX protein, human; 0 / Histones; 0 / Intracellular Signaling Peptides and Proteins; 0 / TP53BP1 protein, human; 0 / Tumor Suppressor p53-Binding Protein 1
  •  go-up   go-down


5. Castellan M, Gosalbez R, Perez-Brayfield M, Healey P, McDonald R, Labbie A, Lendvay T: Tumor in bladder reservoir after gastrocystoplasty. J Urol; 2007 Oct;178(4 Pt 2):1771-4; discussion 1774
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • PURPOSE: To our knowledge the risk of malignancy in patients with previous bladder augmentation with stomach is unknown.
  • We report 3 cases of gastric adenocarcinoma and 1 of transitional cell carcinoma after augmentation cystoplasty with stomach with long-term followup.
  • MATERIALS AND METHODS: Between August 1989 and August 2002, 119 patients underwent augmentation cystoplasty with stomach at our 2 institutions (University of Miami School of Medicine, and Seattle Children's Hospital and Regional Medical Center).
  • Preoperative diagnosis was neurogenic bladder in 3 patients and posterior urethral valve in 1.
  • Three patients had gastric adenocarcinoma, while the other had poorly differentiated transitional cell carcinoma.
  • CONCLUSIONS: Patients who undergo bladder augmentation with a gastric remnant are at increased risk for malignancy, probably similar to that in patients with enterocystoplasty.
  • Patients should be followed annually with ultrasound, and cystoscopy should be performed annually starting 10 years after gastrocystoplasty unless they have abnormal ultrasound, hematuria or another cancer risk factor.
  • [MeSH-major] Adenocarcinoma / etiology. Carcinoma, Transitional Cell / etiology. Gastric Mucosa / transplantation. Urinary Bladder Neoplasms / etiology. Urinary Diversion / adverse effects. Urinary Reservoirs, Continent / adverse effects

  • MedlinePlus Health Information. consumer health - Bladder Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17707009.001).
  • [ISSN] 0022-5347
  • [Journal-full-title] The Journal of urology
  • [ISO-abbreviation] J. Urol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


6. Wu J, He YJ, Tong SL: [Gastric collision tumor (adenocarcinoma and gastrointestinal stromal tumor): report of a case]. Zhonghua Bing Li Xue Za Zhi; 2010 Aug;39(8):563-4
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Gastric collision tumor (adenocarcinoma and gastrointestinal stromal tumor): report of a case].
  • [MeSH-major] Adenocarcinoma / pathology. Gastrointestinal Stromal Tumors / pathology. Neoplasms, Multiple Primary / pathology. Stomach Neoplasms / pathology

  • MedlinePlus Health Information. consumer health - Stomach Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 21055041.001).
  • [ISSN] 0529-5807
  • [Journal-full-title] Zhonghua bing li xue za zhi = Chinese journal of pathology
  • [ISO-abbreviation] Zhonghua Bing Li Xue Za Zhi
  • [Language] chi
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] China
  • [Chemical-registry-number] 68238-35-7 / Keratins; EC 2.7.10.1 / Proto-Oncogene Proteins c-kit
  •  go-up   go-down


7. Xu CY, Guo JL, Jiang ZN, Xie SD, Shen JG, Shen JY, Wang LB: Prognostic role of estrogen receptor alpha and estrogen receptor beta in gastric cancer. Ann Surg Oncol; 2010 Sep;17(9):2503-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Prognostic role of estrogen receptor alpha and estrogen receptor beta in gastric cancer.
  • BACKGROUND: The presence of estrogen receptor alpha (ERalpha) and estrogen receptor beta (ERbeta) have been reported in cell and tissue level in gastric cancer, but its impact on patients' survival remains unclear.
  • This study was designed to investigate the expression level of ERalpha and ERbeta and to assess clinical significance of ERalpha and ERbeta expression in gastric cancer.
  • METHODS: The expression level of ERalpha and ERbeta were assessed by reverse-transcriptase polymerase chain reaction (RT-PCR) in 35 surgically resected gastric cancer and corresponding normal tissues and by immunohistochemical staining in 211 surgically resected gastric cancer and match normal tissues.
  • RESULTS: The expression level between ERalpha mRNA expression in gastric cancer tissues and match normal tissues had no statistically significant difference.
  • The ERbeta mRNA level in normal tissues was significantly higher than that observed in gastric cancer tissues (P = 0.001).
  • Forty-eight of 211 (22.7%) gastric cancer tissues showed positive expression of ERalpha and ERbeta detected in gastric cancer.
  • ERalpha-positive expression correlated with poorer overall survival (P = 0.014), as did the absence of ERbeta expression in patients with gastric cancer (P = 0.001).
  • CONCLUSIONS: Our results indicated that ERalpha and ERbeta were expressed in both gastric cancer and corresponding normal tissues.
  • [MeSH-major] Adenocarcinoma / metabolism. Biomarkers, Tumor / metabolism. Estrogen Receptor alpha / metabolism. Estrogen Receptor beta / metabolism. Gastric Mucosa / metabolism. Stomach Neoplasms / metabolism

  • MedlinePlus Health Information. consumer health - Stomach Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20339947.001).
  • [ISSN] 1534-4681
  • [Journal-full-title] Annals of surgical oncology
  • [ISO-abbreviation] Ann. Surg. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / Estrogen Receptor alpha; 0 / Estrogen Receptor beta; 0 / RNA, Messenger; 0 / RNA, Neoplasm
  •  go-up   go-down


8. Soung YH, Lee JW, Kim SY, Park WS, Nam SW, Lee JY, Yoo NJ, Lee SH: Mutational analysis of proapoptotic caspase-9 gene in common human carcinomas. APMIS; 2006 Apr;114(4):292-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Mounting evidence indicates that deregulation of apoptosis is involved in the mechanisms of cancer development.
  • To explore the possibility that the genetic alterations of caspase-9 might be involved in the development of human cancers, we analyzed the entire coding region and all splice sites of the human caspase-9 gene for the detection of somatic mutations in a series of 353 cancers, including 180 gastric, 104 colorectal and 69 lung adenocarcinomas.
  • The mutations were observed in 2 of 104 colorectal carcinomas and 1 of 180 gastric carcinomas.
  • These data indicate that the caspase-9 gene is rarely mutated in gastric, colorectal and lung adenocarcinomas, and suggest that caspase-9 gene mutation may not contribute to the pathogenesis of these cancers.
  • [MeSH-major] Adenocarcinoma / genetics. Apoptosis / genetics. Caspases / genetics. Colonic Neoplasms / genetics. Lung Neoplasms / genetics. Stomach Neoplasms / genetics

  • MedlinePlus Health Information. consumer health - Lung Cancer.
  • MedlinePlus Health Information. consumer health - Stomach Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16689829.001).
  • [ISSN] 0903-4641
  • [Journal-full-title] APMIS : acta pathologica, microbiologica, et immunologica Scandinavica
  • [ISO-abbreviation] APMIS
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Denmark
  • [Chemical-registry-number] EC 3.4.22.- / CASP9 protein, human; EC 3.4.22.- / Caspase 9; EC 3.4.22.- / Caspases
  •  go-up   go-down


9. Mariette C: [A case of stomach cancer]. J Chir (Paris); 2005 May-Jun;142(3):184-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [A case of stomach cancer].
  • [Transliterated title] Un cancer de l'estomac.
  • [MeSH-major] Adenocarcinoma. Pyloric Antrum. Stomach Neoplasms

  • MedlinePlus Health Information. consumer health - Stomach Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16142084.001).
  • [ISSN] 0021-7697
  • [Journal-full-title] Journal de chirurgie
  • [ISO-abbreviation] J Chir (Paris)
  • [Language] fre
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] France
  • [Chemical-registry-number] 0 / Cadherins
  •  go-up   go-down


10. Schmeda-Hirschmann G, Pertino MW, Rodriguez JA, Monsalve F, Droguett D, Theoduloz C: Synthesis, gastroprotective effect and cytotoxicity of new amino acid diterpene monoamides and diamides. Molecules; 2010;15(10):7378-94
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The new compounds were evaluated for their gastroprotective effect in the ethanol/HCl-induced gastric lesions model in mice, as well as for cytotoxicity using the following human cell lines: normal lung fibroblasts (MRC-5), gastric adenocarcinoma cells (AGS) and liver hepatocellular carcinoma (Hep G2).
  • A dose-response experiment showed that at 25 mg/kg the C-15 leucyl and C-15,19-dileucylester amides of junicedric acid reduced gastric lesions by about 65.6 and 49.6%, respectively, with an effect comparable to lansoprazole at 20 mg/kg (79.3% lesion reduction).
  • Several compounds presented a strong gastroprotective effect, reducing gastric lesions in the 70.9-87.8% range.
  • [MeSH-major] Amino Acids. Diamide. Diterpenes. Stomach Ulcer / drug therapy
  • [MeSH-minor] Animals. Cell Line. Ethanol / pharmacology. Gastric Mucosa / pathology. Humans. Male. Mice. Molecular Structure

  • Hazardous Substances Data Bank. ETHANOL .
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20966879.001).
  • [ISSN] 1420-3049
  • [Journal-full-title] Molecules (Basel, Switzerland)
  • [ISO-abbreviation] Molecules
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Switzerland
  • [Chemical-registry-number] 0 / Amino Acids; 0 / Diterpenes; 0 / diterpene 8(17)-labden-15,19-dioic acid; 10465-78-8 / Diamide; 3K9958V90M / Ethanol
  •  go-up   go-down


11. Catalano G, Urbani L, De Simone P, Morelli L, Coletti L, Cioni R, Matocci G, Mosca F, Filipponi F: Expanding indications for TIPSS: portal decompression before elective oncologic gastric surgery in cirrhotic patients. J Clin Gastroenterol; 2005 Nov-Dec;39(10):921-3
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Expanding indications for TIPSS: portal decompression before elective oncologic gastric surgery in cirrhotic patients.
  • [MeSH-major] Elective Surgical Procedures. Gastrectomy. Hypertension, Portal / prevention & control. Liver Cirrhosis, Alcoholic / surgery. Portasystemic Shunt, Transjugular Intrahepatic. Stomach Neoplasms / surgery
  • [MeSH-minor] Adenocarcinoma / surgery. Esophageal and Gastric Varices / surgery. Humans. Male. Middle Aged. Preoperative Care. Stomach Ulcer / surgery

  • MedlinePlus Health Information. consumer health - Stomach Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16208123.001).
  • [ISSN] 0192-0790
  • [Journal-full-title] Journal of clinical gastroenterology
  • [ISO-abbreviation] J. Clin. Gastroenterol.
  • [Language] eng
  • [Publication-type] Case Reports; Letter
  • [Publication-country] United States
  •  go-up   go-down


12. Im M, Kye KC, Kim JM, Lee JH: Extramammary Paget's disease of the scrotum with adenocarcinoma of the stomach. J Am Acad Dermatol; 2007 Aug;57(2 Suppl):S43-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Extramammary Paget's disease of the scrotum with adenocarcinoma of the stomach.
  • [MeSH-major] Adenocarcinoma / pathology. Paget Disease, Extramammary / pathology. Scrotum. Skin Neoplasms / pathology. Stomach Neoplasms / pathology

  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • MedlinePlus Health Information. consumer health - Stomach Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17637372.001).
  • [ISSN] 1097-6787
  • [Journal-full-title] Journal of the American Academy of Dermatology
  • [ISO-abbreviation] J. Am. Acad. Dermatol.
  • [Language] eng
  • [Publication-type] Case Reports; Letter; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  •  go-up   go-down


13. Ullah MZ, Patel H, Lauffer GL, Tanner A: Second case report of a metachronous double primary gastric cancer. Br J Hosp Med (Lond); 2005 Sep;66(9):538-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Second case report of a metachronous double primary gastric cancer.
  • [MeSH-major] Adenocarcinoma / drug therapy. Antineoplastic Combined Chemotherapy Protocols / therapeutic use. Lymphoma, Non-Hodgkin / surgery. Neoplasms, Second Primary / surgery. Stomach Neoplasms / drug therapy

  • MedlinePlus Health Information. consumer health - Stomach Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16200801.001).
  • [ISSN] 1750-8460
  • [Journal-full-title] British journal of hospital medicine (London, England : 2005)
  • [ISO-abbreviation] Br J Hosp Med (Lond)
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] England
  •  go-up   go-down


14. Schneider F, Lang N, Reibke R, Michaely HJ, Hiddemann W, Ostermann H: Plesiomonas shigelloides pneumonia. Med Mal Infect; 2009 Jun;39(6):397-400
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • We report the first case of pneumonia caused by P. shigelloides in a 76-year-old woman who had undergone a curative gastrectomy and esophageal-jejunostomy due to a low differentiated adenocarcinoma of the stomach (pT2, pN1 pMx, G3, R0, Lauren: intestinal type).
  • Although antibiotic treatment led to a decrease of inflammation parameters and decrease of the pulmonary infiltrate the patient died due to development of torsades de pointes tachycardia leading to ventricular fibrillation and hypoxic brain damage.
  • [MeSH-major] Adenocarcinoma / surgery. Gastrectomy / adverse effects. Gram-Negative Bacterial Infections / etiology. Jejunostomy / adverse effects. Plesiomonas. Stomach Neoplasms / surgery
  • [MeSH-minor] Aged. Female. Humans. Inflammation / microbiology. Tachycardia / etiology. Torsades de Pointes / etiology. Unconsciousness / etiology. Ventricular Fibrillation / etiology

  • MedlinePlus Health Information. consumer health - Stomach Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19167851.001).
  • [ISSN] 0399-077X
  • [Journal-full-title] Médecine et maladies infectieuses
  • [ISO-abbreviation] Med Mal Infect
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] France
  •  go-up   go-down


15. Ran JT, Zhou YN, Tang CW, Lu JR, Wu J, Lu H, Yang GD: [Celecoxib induces apoptosis and inhibits angiogenesis in gastric cancer]. Zhonghua Zhong Liu Za Zhi; 2008 Jun;30(6):448-51
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Celecoxib induces apoptosis and inhibits angiogenesis in gastric cancer].
  • OBJECTIVE: The aim of this study was to explore the effect of celecoxib, a cyclooxygenase-2 inhibitor, on induction of apoptosis and inhibition of angiogenesis in gastric cancer.
  • METHODS: Fifty nine gastric cancer patients were randomly divided into 2 groups: celecoxib group (n = 37) and control group (n = 22).
  • The expression level of COX-2 and VEGF in the gastric cancer tissues was significantly decreased in the celecoxib group compared with those in the control group (P < 0.05).
  • CONCLUSION: Oral intake of celecoxib can induce apoptosis and suppress angiogenesis in gastric cancer.
  • It may become an effective agent in the treatment of gastric cancer.
  • [MeSH-major] Apoptosis / drug effects. Cyclooxygenase 2 Inhibitors / pharmacology. Neovascularization, Pathologic / prevention & control. Pyrazoles / pharmacology. Stomach Neoplasms / pathology. Sulfonamides / pharmacology
  • [MeSH-minor] Adenocarcinoma / metabolism. Adenocarcinoma / pathology. Adult. Aged. Celecoxib. Cyclooxygenase 2 / metabolism. Female. Humans. Male. Microvessels / pathology. Microvessels / ultrastructure. Middle Aged. Vascular Endothelial Growth Factor A / metabolism

  • MedlinePlus Health Information. consumer health - Stomach Cancer.
  • Hazardous Substances Data Bank. CELECOXIB .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19024521.001).
  • [ISSN] 0253-3766
  • [Journal-full-title] Zhonghua zhong liu za zhi [Chinese journal of oncology]
  • [ISO-abbreviation] Zhonghua Zhong Liu Za Zhi
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
  • [Publication-country] China
  • [Chemical-registry-number] 0 / Cyclooxygenase 2 Inhibitors; 0 / Pyrazoles; 0 / Sulfonamides; 0 / Vascular Endothelial Growth Factor A; EC 1.14.99.1 / Cyclooxygenase 2; JCX84Q7J1L / Celecoxib
  •  go-up   go-down


16. Spiliotis J, Karnabatidis D, Vaxevanidou A, Datsis AC, Rogdakis A, Zacharis G, Siamblis D: Acute cholangitis due to afferent loop syndrome after a Whipple procedure: a case report. Cases J; 2009;2:6339
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • INTRODUCTION: Patients with resection of stomach and especially with Billroth II reconstruction (gastro jejunal anastomosis), are more likely to develop afferent loop syndrome which is a rare complication.
  • CASE PRESENTATION: A 54-year-old Greek male had undergone a pancreato-duodenectomy (Whipple procedure) one year earlier due to a pancreatic adenocarcinoma.
  • The diagnosis is difficult and the interventional radiology gives all the details to support the therapeutic decision making.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Eur Radiol. 2008 Mar;18(3):448-56 [17960388.001]
  • [Cites] J Nippon Med Sch. 2006 Aug;73(4):226-30 [16936449.001]
  • [Cites] Eur J Radiol. 2005 Mar;53(3):341-52 [15741008.001]
  • [Cites] Am J Gastroenterol. 1994 Jun;89(6):942-4 [8198112.001]
  • [Cites] Z Gastroenterol. 2002 Feb;40(2):77-9 [11857102.001]
  • [Cites] Br J Surg. 2004 May;91(5):528-39 [15122602.001]
  • [Cites] Hepatogastroenterology. 2004 Mar-Apr;51(56):606-8 [15086215.001]
  • [Cites] Abdom Imaging. 2003 Sep-Oct;28(5):624-30 [14628863.001]
  • [Cites] Dig Dis Sci. 1979 Jan;24(1):74-6 [428293.001]
  • (PMID = 19918578.001).
  • [ISSN] 1757-1626
  • [Journal-full-title] Cases journal
  • [ISO-abbreviation] Cases J
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Other-IDs] NLM/ PMC2769288
  •  go-up   go-down


17. Peng SY, Hong DF, Liu YB, Li JT, Tao F, Tan ZJ: [A pancreas suture-less type II binding pancreaticogastrostomy]. Zhonghua Wai Ke Za Zhi; 2009 Dec 1;47(23):1764-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • METHODS: From November 2008 to May 2009, 26 patients underwent pancreaticoduodenectomy and mid-segmentectomy of pancreas with type II BPG reconstruction, including 13 cases of pancreatic head cancer, 3 cases of duodenal adenocarcinoma, 2 cases of ampullary carcinoma, 4 cases of cholangiocarcinoma, 1 case of bile duct cell severe atypical hyperplasia, and 1 case of stomach cancer.
  • The process of type II BPG was described as the following: after pancreas remnant was mobilized for 2-3 cm, a piece of sero-muscular layer at the posterior gastric wall was excised and then a sero-muscular depth purse-suturing with 3-0 prolene was pre-placed (outer purse-string).
  • Incising anterior gastric wall or opening part of the closed distal gastric stump, the mucosa layer at the sero-muscular defect was incised and then purse-suture at the mucosal tube was pre-placed (inner purse-string).
  • Through the two pre-placed purse-strings, the pancreas remnant was pulled into the gastric lumen and then posterior gastric wall was pushed backward to keep it closely in contact with the retro-peritoneal wall.
  • Postoperative complications included 1 case of ascites, 2 cases of delayed gastric emptying and 1 case of intra-abdominal bleeding.
  • [MeSH-major] Anastomosis, Surgical / methods. Pancreas / surgery. Stomach / surgery

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20193541.001).
  • [ISSN] 0529-5815
  • [Journal-full-title] Zhonghua wai ke za zhi [Chinese journal of surgery]
  • [ISO-abbreviation] Zhonghua Wai Ke Za Zhi
  • [Language] chi
  • [Publication-type] English Abstract; Evaluation Studies; Journal Article
  • [Publication-country] China
  •  go-up   go-down


18. Hirasaki S, Kanzaki H, Fujita K, Matsumura S, Matsumoto E, Yumoto E, Suzuki S: Papillary adenocarcinoma occurring in a gastric hyperplastic polyp observed by magnifying endoscopy and treated with endoscopic mucosal resection. Intern Med; 2008;47(10):949-52
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Papillary adenocarcinoma occurring in a gastric hyperplastic polyp observed by magnifying endoscopy and treated with endoscopic mucosal resection.
  • He had been diagnosed with gastric hyperplastic polyp 4 years previously.
  • Histological examination revealed that a part of the polyp surface was replaced with papillary adenocarcinoma.
  • Diagnosis of papillary adenocarcinoma in a hyperplastic polyp with mucosal invasion was made.
  • Magnifying endoscopy was useful for the detection of gastric cancer occurring in the hyperplastic polyp in the present case.
  • [MeSH-major] Adenocarcinoma, Papillary / pathology. Polyps / pathology. Stomach Neoplasms / pathology

  • MedlinePlus Health Information. consumer health - Stomach Cancer.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18480580.001).
  • [ISSN] 1349-7235
  • [Journal-full-title] Internal medicine (Tokyo, Japan)
  • [ISO-abbreviation] Intern. Med.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Japan
  •  go-up   go-down


19. Melo Barbosa HP, Martins LC, Dos Santos SE, Demachki S, Assumpção MB, Aragão CD, de Oliveira Corvelo TC: Interleukin-1 and TNF-alpha polymorphisms and Helicobacter pylori in a Brazilian Amazon population. World J Gastroenterol; 2009 Mar 28;15(12):1465-71
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The histopathological parameters in the gastric biopsies of the patients were according to the Sydney classification.
  • RESULTS: A comparison of the frequencies of the different polymorphisms studied among the patients and the control group demonstrated that the allele IL-1RN*2 was more frequent among patients with gastric ulcers and adenocarcinoma.
  • Carriers of the allele IL-RN*2 and those with reactive serology for anti-CagA IgG had a greater risk of developing peptic ulcer and gastric adenocarcinoma, as well as a higher degree of inflammation and neutrophilic activity in the gastric mucosa.
  • CONCLUSION: Our results indicate a positive association between IL-1RN gene polymorphism and infection by positive H pylori CagA strains and the development of gastric ulcers and adenocarcinoma.
  • [MeSH-minor] Adenocarcinoma / genetics. Brazil / epidemiology. Culture. Gastric Mucosa / pathology. Gene Frequency. Humans. Inflammation / pathology. Socioeconomic Factors. Stomach Neoplasms / genetics. Stomach Ulcer / genetics

  • MedlinePlus Health Information. consumer health - Helicobacter Pylori Infections.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Proc Natl Acad Sci U S A. 1999 Dec 7;96(25):14559-64 [10588744.001]
  • [Cites] Nature. 2000 Mar 23;404(6776):398-402 [10746728.001]
  • [Cites] Med Clin North Am. 2000 Sep;84(5):1125-36, viii [11026921.001]
  • [Cites] Gut. 2001 Jun;48(6):743-7 [11358884.001]
  • [Cites] Gastroenterology. 2001 Oct;121(4):823-9 [11606496.001]
  • [Cites] Rev Soc Bras Med Trop. 2002 Jul-Aug;35(4):307-10 [12170324.001]
  • [Cites] Gastroenterology. 2002 Dec;123(6):1793-803 [12454835.001]
  • [Cites] Proc Natl Acad Sci U S A. 2003 Jan 7;100(1):177-82 [12509516.001]
  • [Cites] Gastroenterology. 2003 May;124(5):1193-201 [12730860.001]
  • [Cites] Arq Gastroenterol. 2002 Oct-Dec;39(4):222-32 [12870081.001]
  • [Cites] Mem Inst Oswaldo Cruz. 2003 Sep;98(6):817-21 [14595461.001]
  • [Cites] Gut. 2003 Dec;52(12):1684-9 [14633943.001]
  • [Cites] Aliment Pharmacol Ther. 2004 Jul 15;20(2):203-11 [15233701.001]
  • [Cites] Gastroenterology. 2004 Jul;127(1):73-9 [15236174.001]
  • [Cites] Nucleic Acids Res. 1976 Sep;3(9):2303-8 [987581.001]
  • [Cites] Gastroenterology. 1992 Jun;102(6):2177-8 [1587446.001]
  • [Cites] Biometrics. 1992 Jun;48(2):361-72 [1637966.001]
  • [Cites] Mol Biol Evol. 1995 Sep;12(5):921-7 [7476138.001]
  • [Cites] Heredity (Edinb). 1996 Apr;76 ( Pt 4):377-83 [8626222.001]
  • [Cites] Gastroenterology. 1997 Jan;112(1):92-9 [8978347.001]
  • [Cites] Proc Natl Acad Sci U S A. 1997 Apr 1;94(7):3195-9 [9096369.001]
  • [Cites] Helicobacter. 1997 Jul;2 Suppl 1:S17-24 [9432349.001]
  • [Cites] Gut. 1999 Jul;45(1):24-31 [10369700.001]
  • [Cites] Am J Phys Anthropol. 1999 Jun;109(2):175-80 [10378456.001]
  • [Cites] J Exp Med. 1999 Jun 21;189(12):1863-74 [10377182.001]
  • [Cites] Int J Cancer. 2005 Jul 10;115(5):678-83 [15704154.001]
  • [Cites] Scand J Gastroenterol. 2005 May;40(5):530-9 [16036505.001]
  • [Cites] Cancer Epidemiol Biomarkers Prev. 2005 Aug;14(8):1869-73 [16103428.001]
  • [Cites] Chin Med J (Engl). 2005 Nov 20;118(22):1870-8 [16313841.001]
  • [Cites] Mem Inst Oswaldo Cruz. 2005 Dec;100(8):875-81 [16444419.001]
  • [Cites] J Clin Pathol. 2001 Sep;54(9):703-6 [11533078.001]
  • (PMID = 19322919.001).
  • [ISSN] 2219-2840
  • [Journal-full-title] World journal of gastroenterology
  • [ISO-abbreviation] World J. Gastroenterol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] China
  • [Chemical-registry-number] 0 / Interleukin-1; 0 / Tumor Necrosis Factor-alpha
  • [Other-IDs] NLM/ PMC2665140
  •  go-up   go-down


20. Sharma A, Nitharwal RG, Singh B, Dar A, Dasgupta S, Dhar SK: Helicobacter pylori single-stranded DNA binding protein--functional characterization and modulation of H. pylori DnaB helicase activity. FEBS J; 2009 Jan;276(2):519-31
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Helicobacter pylori, an important bacterial pathogen, causes gastric ulcer and gastric adenocarcinoma in humans.


21. Azem J, Svennerholm AM, Lundin BS: B cells pulsed with Helicobacter pylori antigen efficiently activate memory CD8+ T cells from H. pylori-infected individuals. Clin Immunol; 2006 Feb-Mar;118(2-3):284-91
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Helicobacter pylori infection causes chronic gastritis that may progress to peptic ulcers or gastric adenocarcinoma and thereby cause major world-wide health problems.
  • We further show that the majority of CD8+ T cells in H. pylori-infected gastric mucosa are memory cells, and that memory CD8+ T cells sorted from peripheral blood of H. pylori-infected individuals respond 15-fold more to H. pylori urease compared to memory cells from uninfected subjects.
  • [MeSH-minor] Adult. Cell Proliferation. Cells, Cultured. Gastric Mucosa / immunology. Gastric Mucosa / microbiology. Humans. Middle Aged. Monocytes / immunology

  • MedlinePlus Health Information. consumer health - Helicobacter Pylori Infections.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16324887.001).
  • [ISSN] 1521-6616
  • [Journal-full-title] Clinical immunology (Orlando, Fla.)
  • [ISO-abbreviation] Clin. Immunol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antigens, Bacterial
  •  go-up   go-down


22. Chen CY, Hsu JS, Wu DC, Kang WY, Hsieh JS, Jaw TS, Wu MT, Liu GC: Gastric cancer: preoperative local staging with 3D multi-detector row CT--correlation with surgical and histopathologic results. Radiology; 2007 Feb;242(2):472-82
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Gastric cancer: preoperative local staging with 3D multi-detector row CT--correlation with surgical and histopathologic results.
  • PURPOSE: To prospectively evaluate accuracy of multi-detector row computed tomographic (CT) images for preoperative staging of gastric cancer by using surgical and histopathologic results as reference standards.
  • Fifty-five consecutive patients with gastric cancer (38 men, 17 women; age range, 37-84 years; mean age, 63 years) underwent preoperative CT.
  • All received 6 g of gas-producing crystals before unenhanced CT scanning for gastric distention and virtual gastroscopy.
  • Overall accuracy in assessment of tumor invasion of the gastric wall (T stage) was significantly better with MPR images (89% [49 of 55]) than with transverse images (73% [40 of 55]) (P < .01).
  • CONCLUSION: Multi-detector row CT with combined water and air distention can improve the accuracy of preoperative staging of gastric cancer.
  • [MeSH-major] Image Processing, Computer-Assisted / methods. Imaging, Three-Dimensional / methods. Stomach Neoplasms / radiography. Tomography, X-Ray Computed / methods
  • [MeSH-minor] Adenocarcinoma / pathology. Adenocarcinoma / radiography. Adenocarcinoma / secondary. Adenocarcinoma / surgery. Adult. Aged. Aged, 80 and over. Contrast Media. Female. Gastroscopy / methods. Humans. Insufflation. Iohexol / analogs & derivatives. Lymphatic Metastasis / radiography. Male. Middle Aged. Neoplasm Invasiveness. Neoplasm Staging. Pneumoradiography. Preoperative Care. Prospective Studies. Radiographic Image Enhancement / methods. Time Factors. Water

  • MedlinePlus Health Information. consumer health - CT Scans.
  • MedlinePlus Health Information. consumer health - Stomach Cancer.
  • Hazardous Substances Data Bank. Water .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] (c) RSNA, 2007.
  • (PMID = 17255419.001).
  • [ISSN] 0033-8419
  • [Journal-full-title] Radiology
  • [ISO-abbreviation] Radiology
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Contrast Media; 059QF0KO0R / Water; 4419T9MX03 / Iohexol; 712BAC33MZ / iopromide
  •  go-up   go-down


23. Siew LC, Huang C, Fleming J: Gastric adenocarcinoma mistakenly diagnosed as an eating disorder: case report. Int J Eat Disord; 2010 Apr;43(3):286-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Gastric adenocarcinoma mistakenly diagnosed as an eating disorder: case report.
  • OBJECTIVE: A number of organic conditions may mimic the symptoms of an eating disorder, however, gastric outlet obstruction mimicking anorexia nervosa has rarely been reported.
  • METHOD: We report the case of a 51-year-old female admitted to an eating disorders unit with an initial diagnosis of anorexia nervosa.
  • RESULTS: The patient's upper gastrointestinal symptoms and weight loss were found to be secondary to gastric outlet obstruction from a gastric adenocarcinoma.
  • Coincidental psychosocial stressors and past psychiatric history, among other factors, had confounded the diagnosis.
  • DISCUSSION: Organic causes of weight loss and upper gastrointestinal symptoms need to be fully excluded prior to making the diagnosis of an eating disorder, particularly when there are atypical features in the presentation.
  • [MeSH-major] Adenocarcinoma / diagnosis. Anorexia Nervosa / diagnosis. Diagnostic Errors. Stomach Neoplasms / diagnosis
  • [MeSH-minor] Body Mass Index. Depressive Disorder, Major / diagnosis. Depressive Disorder, Major / psychology. Dyspepsia / etiology. Energy Intake. Female. Gastric Outlet Obstruction / diagnosis. Gastric Outlet Obstruction / psychology. Gastroscopy. Humans. Middle Aged. Thinness / diagnosis. Thinness / psychology. Tomography, X-Ray Computed. Vomiting / etiology. Weight Loss

  • MedlinePlus Health Information. consumer health - Stomach Cancer.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19365820.001).
  • [ISSN] 1098-108X
  • [Journal-full-title] The International journal of eating disorders
  • [ISO-abbreviation] Int J Eat Disord
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


24. Ihn MH, Kim YJ, Kim JJ, Cho JY, Jin SY: A case of thyroid metastasis originating from early gastric cancer. J Korean Med Sci; 2009 Dec;24(6):1230-3
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] A case of thyroid metastasis originating from early gastric cancer.
  • We report a rare case of thyroid metastasis from early gastric cancer with lymph node metastasis in a 63-yr old woman.
  • She was diagnosed with metastatic adenocarcinoma one and a half years after distal subtotal gastrectomy, by fine needle aspiration (FNA) using thyroid sonography.
  • Thyroid metastasis from gastric cancer is extremely rare, and this case is particular in that it is the first report of thyroid metastasis from early gastric cancer.
  • [MeSH-major] Adenocarcinoma. Lymphatic Metastasis / pathology. Stomach Neoplasms / pathology. Thyroid Neoplasms / secondary

  • Genetic Alliance. consumer health - Thyroid Cancer.
  • MedlinePlus Health Information. consumer health - Stomach Cancer.
  • MedlinePlus Health Information. consumer health - Thyroid Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Surg Today. 2000;30(11):1005-7 [11110395.001]
  • [Cites] Ann Surg Oncol. 2006 Mar;13(3):377-85 [16450215.001]
  • [Cites] J Surg Oncol. 1981;17(1):15-23 [7230827.001]
  • [Cites] Cancer. 1981 Oct 1;48(7):1647-55 [6169423.001]
  • [Cites] Surg Gynecol Obstet. 1982 Oct;155(4):503-5 [7123465.001]
  • [Cites] Am J Surg. 1985 Oct;150(4):519-23 [4051119.001]
  • [Cites] Cancer. 1986 Jul 1;58(1):119-26 [2423220.001]
  • [Cites] Int Surg. 1986 Oct-Dec;71(4):244-7 [3557850.001]
  • [Cites] Jpn J Surg. 1989 Jul;19(4):480-4 [2810962.001]
  • [Cites] Br J Surg. 1992 Mar;79(3):245-7 [1555092.001]
  • [Cites] Surg Today. 1993;23(2):153-8 [8467161.001]
  • [Cites] Br J Surg. 1993 Mar;80(3):325-8 [8472141.001]
  • [Cites] Cancer. 1993 Dec 1;72(11):3174-8 [8242540.001]
  • [Cites] Br J Surg. 1995 Jul;82(7):952-6 [7648118.001]
  • [Cites] Cancer. 1997 Feb 1;79(3):574-8 [9028370.001]
  • [Cites] J Surg Oncol. 1997 Jan;64(1):42-7 [9040800.001]
  • [Cites] Arch Pathol Lab Med. 1998 Jan;122(1):37-41 [9448014.001]
  • [Cites] S Afr Med J. 1977 Apr 9;51(15):509-12 [854830.001]
  • (PMID = 19949691.001).
  • [ISSN] 1598-6357
  • [Journal-full-title] Journal of Korean medical science
  • [ISO-abbreviation] J. Korean Med. Sci.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Korea (South)
  • [Other-IDs] NLM/ PMC2775883
  • [Keywords] NOTNLM ; Lymph Node Metastasis / Stomach Neoplasms / Thyroid Metastasis
  •  go-up   go-down


25. Kim SS, Yoo NJ, Jeong EG, Kim MS, Lee SH: Expression of NEDD4-1, a PTEN regulator, in gastric and colorectal carcinomas. APMIS; 2008 Sep;116(9):779-84
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Expression of NEDD4-1, a PTEN regulator, in gastric and colorectal carcinomas.
  • Despite the importance of NEDD4-1 in PTEN regulation in cancer cells, expression of NEDD4-1 protein in cancer tissues is unknown.
  • The aim of this study was to analyze NEDD4-1 expression in colorectal and gastric cancer tissues.
  • We investigated NEDD4-1 protein expression in 103 colorectal and 60 gastric carcinoma tissues by immunohistochemistry using a tissue microarray approach.
  • In the cancers, expression of NEDD4-1 was detected in 82 (80%) of the colorectal carcinomas and 45 (75%) of the gastric carcinomas in cytoplasm.
  • By contrast, the normal mucosal cells of both stomach and colon showed no or very weak expression of NEDD4-1.
  • Our data indicate that NEDD4-1 overexpression is a feature of both colorectal and gastric carcinomas.
  • The increased expression of NEDD4-1 in malignant gastric and colorectal cells compared to their normal epithelial cells suggests that NEDD4-1 expression may play a role in colorectal and gastric cancer development.
  • [MeSH-major] Adenocarcinoma / enzymology. Colorectal Neoplasms / enzymology. Stomach Neoplasms / enzymology. Ubiquitin-Protein Ligases / biosynthesis

  • MedlinePlus Health Information. consumer health - Colorectal Cancer.
  • MedlinePlus Health Information. consumer health - Stomach Cancer.
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19024597.001).
  • [ISSN] 0903-4641
  • [Journal-full-title] APMIS : acta pathologica, microbiologica, et immunologica Scandinavica
  • [ISO-abbreviation] APMIS
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Denmark
  • [Chemical-registry-number] 0 / Endosomal Sorting Complexes Required for Transport; EC 3.1.3.67 / PTEN Phosphohydrolase; EC 6.3.2.19 / Nedd4 ubiquitin protein ligases; EC 6.3.2.19 / Ubiquitin-Protein Ligases
  •  go-up   go-down


26. Atienza MR, Varela JM: [Menton neuropathy as initial symptom of metastatic gastric carcinoma]. Neurologia; 2008 Jan-Feb;23(1):71-2
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Menton neuropathy as initial symptom of metastatic gastric carcinoma].
  • [Transliterated title] Neuropatía mentoniana como síntoma inicial de carcinoma gástrico metastásico.
  • [MeSH-major] Adenocarcinoma / secondary. Cranial Nerve Diseases / etiology. Stomach Neoplasms. Trigeminal Nerve
  • [MeSH-minor] Aged. Animals. Chin / innervation. Diagnosis, Differential. Female. Humans

  • MedlinePlus Health Information. consumer health - Stomach Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18365785.001).
  • [ISSN] 0213-4853
  • [Journal-full-title] Neurología (Barcelona, Spain)
  • [ISO-abbreviation] Neurologia
  • [Language] spa
  • [Publication-type] Case Reports; Letter
  • [Publication-country] Spain
  •  go-up   go-down


27. Wakata N, Kiyozuka T, Konno S, Nakazora H, Nomoto N, Sugimoto H, Nemoto H: Autoimmune thrombocytopenic purpura, autoimmune hemolytic anemia and gastric cancer appeared in a patient with myasthenia gravis. Intern Med; 2006;45(7):479-81
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Autoimmune thrombocytopenic purpura, autoimmune hemolytic anemia and gastric cancer appeared in a patient with myasthenia gravis.
  • We report a case of myasthenia gravis (MG) associated with autoimmune thrombocytopenic purpura (AITP) and autoimmune hemolytic anemia (AIHA), and after that gastric cancer appeared.
  • Gastrofiberscopy was performed and biopsy specimens revealed signet cell-type adenocarcinoma.
  • [MeSH-major] Anemia, Hemolytic, Autoimmune / complications. Carcinoma, Signet Ring Cell / complications. Myasthenia Gravis / complications. Purpura, Thrombocytopenic, Idiopathic / complications. Stomach Neoplasms / complications


28. Pan S, Yu Q, Bie M, Liu X: [Adhesion and inhibiting adhesion of Helicobacter pylori to SGC-7901 cell in vitro by four Lactobacilli from human]. Wei Sheng Yan Jiu; 2007 Sep;36(5):618-21
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • OBJECTIVE: To investigate the adherence ability of four Lactobacilli to gastric epithelial cell SGC-7901 and the ability of inhibiting the adherence of Helicobacter pylori to the cells.
  • CONCLUSION: Four Lactobacilli can inhibit the adherence of Helicobacter pylori to gastric epithelial cell SGC-7901 in vitro, and they should be further evaluated in vivo.
  • [MeSH-major] Antibiosis / physiology. Bacterial Adhesion / physiology. Helicobacter pylori / physiology. Lactobacillus / physiology. Stomach Neoplasms / microbiology
  • [MeSH-minor] Adenocarcinoma / microbiology. Adenocarcinoma / pathology. Cell Line, Tumor. Humans

  • MedlinePlus Health Information. consumer health - Stomach Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18095579.001).
  • [ISSN] 1000-8020
  • [Journal-full-title] Wei sheng yan jiu = Journal of hygiene research
  • [ISO-abbreviation] Wei Sheng Yan Jiu
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] China
  •  go-up   go-down


29. Park S, Yeo M, Jin JH, Lee KM, Kim SS, Choi SY, Hahm KB: Inhibitory activities and attenuated expressions of 5-LOX with red ginseng in Helicobacter pylori-infected gastric epithelial cells. Dig Dis Sci; 2007 Apr;52(4):973-82
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Inhibitory activities and attenuated expressions of 5-LOX with red ginseng in Helicobacter pylori-infected gastric epithelial cells.
  • Meyer) can inhibit Helicobacter pylori-induced mitogen-activated protein kinase (MAPK) signaling with repressing either nuclear factor (NF)-kappaB-DNA binding activity or releases of IL-8 and COX-2 in gastric epithelial cells (Dig Dis Sci 50:1218-1227, 2005).
  • The 5-LOX enzyme activities were measured by thin layer chromatography using (14)C-labeled arachidonic acid (AA) and quantified by reverse phase-high performance liquid chromatography in human gastric adenocarcinoma (AGS) cells cocultured with H pylori (ATCC 43504 strain) with or without pretreatment of RGE.
  • RGE inactivated c-jun phosphorylation and repressed redox-sensitive transcriptional activation, led to reduced expression of IL-8 and 5-LOX mRNA in gastric mucosal cells, of which action was very similar to known LOX inhibitor, 200 mumol of geraniin.
  • RGE could be phytoceutical against H pylori infection-associated gastric inflammation through its LOX-inhibiting actions, inhibitory 5-LOX enzyme activity, and attenuating its expression.
  • [MeSH-major] Arachidonate 5-Lipoxygenase / metabolism. Epithelial Cells / metabolism. Gastric Mucosa / metabolism. Helicobacter Infections / metabolism. Helicobacter pylori. Panax. Plant Extracts / pharmacology
  • [MeSH-minor] Adenocarcinoma / metabolism. Adenocarcinoma / microbiology. Arachidonic Acid / metabolism. Chromatography, High Pressure Liquid. Chromatography, Thin Layer. Cyclooxygenase 2 / metabolism. Humans. Hydroxyeicosatetraenoic Acids / metabolism. Lipoxygenase Inhibitors. Mitogen-Activated Protein Kinases / metabolism. Reverse Transcriptase Polymerase Chain Reaction. Signal Transduction. Stomach Neoplasms / metabolism. Stomach Neoplasms / microbiology. Tumor Cells, Cultured

  • MedlinePlus Health Information. consumer health - Helicobacter Pylori Infections.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Biol Chem. 2001 Jan 5;276(1):804-10 [11034994.001]
  • [Cites] Aliment Pharmacol Ther. 2001 Sep;15(9):1271-90 [11552897.001]
  • [Cites] J Physiol Pharmacol. 1996 Mar;47(1):161-75 [8777296.001]
  • [Cites] J Biol Chem. 1956 May;220(1):257-64 [13319343.001]
  • [Cites] Nihon Rinsho. 1993 Dec;51(12):3159-62 [8283625.001]
  • [Cites] Cancer Res. 1992 Apr 1;52(7):1744-9 [1551103.001]
  • [Cites] Infect Immun. 2001 Sep;69(9):5857-63 [11500464.001]
  • [Cites] J Immunol. 1999 Sep 15;163(6):3449-58 [10477617.001]
  • [Cites] J Gastroenterol Hepatol. 2001 Nov;16(11):1197-205 [11903735.001]
  • [Cites] J Immunol. 1998 Mar 1;160(5):2401-7 [9498783.001]
  • [Cites] Life Sci. 1999;65(4):337-53 [10421421.001]
  • [Cites] Basic Life Sci. 1992;59:539-69 [1417694.001]
  • [Cites] J Ethnopharmacol. 1995 Dec 15;49(3):157-62 [8824741.001]
  • [Cites] J Exp Med. 1989 Sep 1;170(3):847-63 [2549166.001]
  • [Cites] Cytokine. 1999 Aug;11(8):606-10 [10433808.001]
  • [Cites] Adv Prostaglandin Thromboxane Leukot Res. 1986;16:353-61 [2949560.001]
  • [Cites] Aliment Pharmacol Ther. 2003 Jul;18 Suppl 1:24-38 [12925138.001]
  • [Cites] Dig Dis Sci. 2005 Jul;50(7):1218-27 [16047463.001]
  • [Cites] J Gastroenterol Hepatol. 2001 Mar;16(3):269-75 [11339417.001]
  • [Cites] Integr Cancer Ther. 2002 Mar;1(1):7-37; discussion 37 [14664746.001]
  • [Cites] Arch Pharm Res. 2001 Aug;24(4):297-9 [11534760.001]
  • [Cites] Am J Physiol Gastrointest Liver Physiol. 2003 Jul;285(1):G163-76 [12606301.001]
  • [Cites] Int Arch Allergy Immunol. 2004 Feb;133(2):113-20 [14739579.001]
  • [Cites] Biochem Biophys Res Commun. 2004 Apr 16;316(4):1065-72 [15044093.001]
  • [Cites] Aliment Pharmacol Ther. 2003 Jun 15;17(12):1535-43 [12823157.001]
  • [Cites] Mutat Res. 2003 Feb-Mar;523-524:75-85 [12628505.001]
  • [Cites] Toxicology. 2002 Mar 20;172(2):149-56 [11882354.001]
  • [Cites] Carcinogenesis. 2004 Sep;25(9):1671-9 [15073046.001]
  • [Cites] Biochem Biophys Res Commun. 2003 Jul 25;307(2):342-9 [12859962.001]
  • [Cites] Gastric Cancer. 2002;5(1):6-15 [12021854.001]
  • [Cites] J Cell Physiol. 1995 Oct;165(1):62-70 [7559807.001]
  • [Cites] N Engl J Med. 2001 Sep 13;345(11):784-9 [11556297.001]
  • [Cites] Planta Med. 2004 Jul;70(7):615-9 [15254854.001]
  • [Cites] Clin Cancer Res. 2004 Dec 1;10(23):8105-13 [15585646.001]
  • [Cites] Int J Tissue React. 1985;7(6):459-62 [3936815.001]
  • [Cites] Biochim Biophys Acta. 1989 Mar 24;990(3):315-20 [2923911.001]
  • [Cites] Food Chem Toxicol. 2003 Oct;41(10 ):1381-90 [12909272.001]
  • [Cites] Helicobacter. 2004 Dec;9(6):632-42 [15610077.001]
  • [Cites] J Gastroenterol Hepatol. 1998 Jun;13(6):566-71 [9715397.001]
  • [Cites] Prostaglandins Leukot Essent Fatty Acids. 2003 Jan;68(1):35-42 [12538088.001]
  • [Cites] Biochem Biophys Res Commun. 2004 Feb 6;314(2):513-8 [14733936.001]
  • (PMID = 17333352.001).
  • [ISSN] 0163-2116
  • [Journal-full-title] Digestive diseases and sciences
  • [ISO-abbreviation] Dig. Dis. Sci.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Hydroxyeicosatetraenoic Acids; 0 / Lipoxygenase Inhibitors; 0 / Plant Extracts; 27YG812J1I / Arachidonic Acid; 467RNW8T91 / 5-hydroxy-6,8,11,14-eicosatetraenoic acid; EC 1.13.11.34 / Arachidonate 5-Lipoxygenase; EC 1.14.99.1 / Cyclooxygenase 2; EC 2.7.11.24 / Mitogen-Activated Protein Kinases
  •  go-up   go-down


30. Sambasivaiah K, Samson S, Ramakrishna, Prasanna V, Shankar AH: Vermian metastasis causing truncal ataxia and hydrocephalus as initial presentation of carcinoma stomach. Trop Gastroenterol; 2008 Apr-Jun;29(2):101-2
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Vermian metastasis causing truncal ataxia and hydrocephalus as initial presentation of carcinoma stomach.
  • The common presentation of carcinoma stomach includes haematemesis, malaena and gastric outlet obstruction.
  • Symptoms due to metastases to the liver and lung as part of the disease progression are usually preceded by the detection of a primary in the stomach.
  • Carcinoma stomach, where the primary is silent, and which presents with truncal ataxia and features of hydrocephalus due to isolated metastatic deposit in the cerebellar vermis is exceptionally rare.
  • [MeSH-major] Adenocarcinoma / secondary. Cerebellar Neoplasms / secondary. Stomach Neoplasms / pathology


31. Park SH, Lee WK, Chung M, Lee Y, Han SH, Bang SM, Cho EK, Shin DB, Lee JH: Paclitaxel versus docetaxel for advanced gastric cancer: a randomized phase II trial in combination with infusional 5-fluorouracil. Anticancer Drugs; 2006 Feb;17(2):225-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Paclitaxel versus docetaxel for advanced gastric cancer: a randomized phase II trial in combination with infusional 5-fluorouracil.
  • Taxanes have clearly demonstrated activities against gastric cancer.
  • We compared the combination of paclitaxel plus 5-fluorouracil (5-FU) (PF) with docetaxel plus 5-FU (DF) as first-line chemotherapy in patients with measurable metastatic gastric cancer.
  • Both PF and DF appear to have efficacy against metastatic gastric cancer, with different, but acceptable, safety profiles.
  • [MeSH-major] Adenocarcinoma / drug therapy. Antineoplastic Combined Chemotherapy Protocols / therapeutic use. Stomach Neoplasms / drug therapy

  • MedlinePlus Health Information. consumer health - Stomach Cancer.
  • Hazardous Substances Data Bank. DOCETAXEL .
  • Hazardous Substances Data Bank. TAXOL .
  • Hazardous Substances Data Bank. FLUOROURACIL .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16428942.001).
  • [ISSN] 0959-4973
  • [Journal-full-title] Anti-cancer drugs
  • [ISO-abbreviation] Anticancer Drugs
  • [Language] eng
  • [Publication-type] Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Taxoids; 15H5577CQD / docetaxel; P88XT4IS4D / Paclitaxel; U3P01618RT / Fluorouracil
  •  go-up   go-down


32. van Heijl M, van Wijngaarden AK, Lagarde SM, Busch OR, van Lanschot JJ, van Berge Henegouwen MI: Intrathoracic manifestations of cervical anastomotic leaks after transhiatal and transthoracic oesophagectomy. Br J Surg; 2010 May;97(5):726-31
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [MeSH-major] Adenocarcinoma / surgery. Carcinoma, Squamous Cell / surgery. Esophageal Neoplasms / surgery. Esophagectomy / methods. Stomach Neoplasms / surgery. Surgical Wound Dehiscence / complications

  • MedlinePlus Health Information. consumer health - Esophageal Cancer.
  • MedlinePlus Health Information. consumer health - Stomach Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright 2010 British Journal of Surgery Society Ltd.
  • [CommentIn] Br J Surg. 2010 Nov;97(11):1745; author reply 1745-6 [20890926.001]
  • (PMID = 20235083.001).
  • [ISSN] 1365-2168
  • [Journal-full-title] The British journal of surgery
  • [ISO-abbreviation] Br J Surg
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  •  go-up   go-down


33. Mikata R, Fukai K, Imazeki F, Arai M, Fujiwara K, Yonemitsu Y, Zhang K, Nabeya Y, Ochiai T, Yokosuka O: BCL2L10 is frequently silenced by promoter hypermethylation in gastric cancer. Oncol Rep; 2010 Jun;23(6):1701-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] BCL2L10 is frequently silenced by promoter hypermethylation in gastric cancer.
  • In gastric cancer, several tumor suppressor and tumor-related genes are silenced by aberrant methylation.
  • Previously, we demonstrated that BCL2L10, which belongs to the pro-apoptotic Bcl-2 family, was transcriptionally repressed by promoter hypermethylation and that its overexpression caused apoptosis and growth inhibition of gastric cancer cells.
  • In this study, we investigated the methylation status of BCL2L10 and its expression in 21 gastric cancer tissues and corresponding non-neoplastic mucosae along with the methylation status of p16, RUNX3, and hMLH1 genes by using methylation specific PCR.
  • As a result, aberrant methylation of BCL2L10 was detected in 38% of gastric cancer and in 24% of corresponding non-neoplastic mucosae and correlated with low expression of BCL2L10.
  • Methylation of p16, RUNX3, and hMLH1 was found in gastric cancer and in corresponding non-neoplastic mucosae at almost similar frequencies as previous reports.
  • In conclusion, our data suggest that silencing of BCL2L10 by aberrant methylation is a common feature in gastric cancer and its inactivation may be involved in the early steps of gastric carcinogenesis.
  • [MeSH-major] Adenocarcinoma / genetics. DNA Methylation. Promoter Regions, Genetic / genetics. Proto-Oncogene Proteins c-bcl-2 / genetics. Stomach Neoplasms / genetics
  • [MeSH-minor] Adaptor Proteins, Signal Transducing / genetics. Aged. Aged, 80 and over. Core Binding Factor Alpha 3 Subunit / genetics. DNA, Neoplasm / genetics. DNA-Binding Proteins / genetics. Female. Gastric Mucosa / metabolism. Gastric Mucosa / pathology. Gene Silencing. Humans. Male. Middle Aged. Neoplasm Proteins / genetics. Nuclear Proteins / genetics. Polycomb Repressive Complex 2. Prognosis. Transcription Factors / genetics

  • MedlinePlus Health Information. consumer health - Stomach Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20428828.001).
  • [ISSN] 1791-2431
  • [Journal-full-title] Oncology reports
  • [ISO-abbreviation] Oncol. Rep.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Greece
  • [Chemical-registry-number] 0 / Adaptor Proteins, Signal Transducing; 0 / BCL2-like 10 protein; 0 / Core Binding Factor Alpha 3 Subunit; 0 / DNA, Neoplasm; 0 / DNA-Binding Proteins; 0 / MLH1 protein, human; 0 / Neoplasm Proteins; 0 / Nuclear Proteins; 0 / P16 protein, human; 0 / Proto-Oncogene Proteins c-bcl-2; 0 / Runx3 protein, human; 0 / Transcription Factors; EC 2.1.1.43 / EZH2 protein, human; EC 2.1.1.43 / Polycomb Repressive Complex 2
  •  go-up   go-down


34. Wolf R, Orion E, Davidovici B: Acral lentigines: a new paraneoplastic syndrome. Int J Dermatol; 2008 Feb;47(2):168-70
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [MeSH-major] Lentigo / etiology. Paraneoplastic Syndromes / diagnosis
  • [MeSH-minor] Adenocarcinoma / complications. Breast Neoplasms / complications. Female. Foot. Hand. Humans. Lymphoma, Large B-Cell, Diffuse / complications. Male. Middle Aged. Neoplasm Recurrence, Local / complications. Stomach Neoplasms / complications

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentIn] Int J Dermatol. 2008 Nov;47(11):1217; author reply 1217-8 [19004079.001]
  • (PMID = 18211490.001).
  • [ISSN] 1365-4632
  • [Journal-full-title] International journal of dermatology
  • [ISO-abbreviation] Int. J. Dermatol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


35. Koshiol J, Wei WQ, Kreimer AR, Ren JS, Gravitt P, Chen W, Kim E, Abnet CC, Zhang Y, Kamangar F, Lin DM, Wang GQ, Roth MJ, Dong ZW, Taylor PR, Qiao YL, Dawsey SM: The gastric cardia is not a target for human papillomavirus-induced carcinogenesis. Cancer Epidemiol Biomarkers Prev; 2010 Apr;19(4):1137-9
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] The gastric cardia is not a target for human papillomavirus-induced carcinogenesis.
  • BACKGROUND: Thousands of people in central Asia die every year from gastric cardia adenocarcinoma (GCA).
  • GCA arises in the transformation zone between the esophagus and the stomach, similar to cervical and oropharyngeal carcinoma, which arise in areas with transformation zone characteristics.
  • The analogous biology of the gastric cardia to the cervix and oropharynx, where human papillomavirus (HPV) is known to cause cancer, raises the possibility that GCA could be a HPV-associated cancer.
  • Given the availability of an effective HPV vaccine and its potential to prevent HPV-associated cancer, we decided to evaluate the prevalence of HPV DNA in GCA.
  • CONCLUSIONS: These results suggest that HPV does not contribute to gastric cardia carcinogenesis in north central China.
  • IMPACT: Because GCA does not seem to be a HPV-associated cancer, prophylactic HPV vaccination is unlikely to affect rates of GCA in China.

  • MedlinePlus Health Information. consumer health - Stomach Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Sex Transm Infect. 1999 Oct;75(5):317-9 [10616355.001]
  • [Cites] Int J Cancer. 2010 Jul 1;127(1):93-100 [19918949.001]
  • [Cites] Sex Transm Infect. 2002 Apr;78(2):135-8 [12081177.001]
  • [Cites] Zhonghua Yi Xue Za Zhi. 2003 Nov 10;83(21):1910-4 [14642078.001]
  • [Cites] J Clin Microbiol. 2004 Jul;42(7):3176-84 [15243079.001]
  • [Cites] J Med Virol. 2004 Sep;74(1):107-16 [15258976.001]
  • [Cites] N Engl J Med. 1986 Oct 23;315(17):1089-90 [3020406.001]
  • [Cites] Obstet Gynecol. 1989 Dec;74(6):950-4 [2555753.001]
  • [Cites] J Infect Dis. 1997 Oct;176(4):1076-9 [9333171.001]
  • [Cites] J Clin Microbiol. 1998 Oct;36(10):3020-7 [9738060.001]
  • [Cites] Cancer Epidemiol Biomarkers Prev. 2005 Feb;14(2):467-75 [15734974.001]
  • [Cites] Mol Aspects Med. 2006 Apr-Jun;27(2-3):126-39 [16469371.001]
  • [Cites] Int J Cancer. 2006 Aug 1;119(3):579-84 [16496409.001]
  • [Cites] J Clin Oncol. 2006 Jun 10;24(17):2606-11 [16763272.001]
  • [Cites] Int J Cancer. 2007 Feb 15;120(4):885-91 [17131323.001]
  • [Cites] Int J Cancer. 2007 Aug 1;121(3):621-32 [17405118.001]
  • [Cites] J Clin Microbiol. 2000 Jan;38(1):357-61 [10618116.001]
  • (PMID = 20332262.001).
  • [ISSN] 1538-7755
  • [Journal-full-title] Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
  • [ISO-abbreviation] Cancer Epidemiol. Biomarkers Prev.
  • [Language] ENG
  • [Grant] United States / CCR NIH HHS / RC / N01RC47702; United States / Intramural NIH HHS / / Z99 CA999999; United States / CCR NIH HHS / RC / N01-RC-47702
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / DNA, Viral
  • [Other-IDs] NLM/ NIHMS179295; NLM/ PMC2852466
  •  go-up   go-down


36. Kim SM, Kim R, Ryu JH, Jho EH, Song KJ, Jang SI, Kee SH: Multinuclear giant cell formation is enhanced by down-regulation of Wnt signaling in gastric cancer cell line, AGS. Exp Cell Res; 2005 Aug 1;308(1):18-28
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Multinuclear giant cell formation is enhanced by down-regulation of Wnt signaling in gastric cancer cell line, AGS.
  • AGS cells, which were derived from malignant gastric adenocarcinoma tissue, lack E-cadherin-mediated cell adhesion but have a high level of nuclear beta-catenin, which suggests altered Wnt signal.
  • [MeSH-major] Adenocarcinoma / metabolism. Giant Cells / metabolism. Intercellular Signaling Peptides and Proteins / metabolism. Signal Transduction / physiology. Stomach Neoplasms / metabolism

  • MedlinePlus Health Information. consumer health - Stomach Cancer.
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15878526.001).
  • [ISSN] 0014-4827
  • [Journal-full-title] Experimental cell research
  • [ISO-abbreviation] Exp. Cell Res.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / CTNNB1 protein, human; 0 / Cadherins; 0 / Culture Media, Serum-Free; 0 / Cytoskeletal Proteins; 0 / Intercellular Signaling Peptides and Proteins; 0 / Trans-Activators; 0 / Wnt Proteins; 0 / beta Catenin
  •  go-up   go-down


37. Giglio P, Weinberg JS, Forman AD, Wolff R, Groves MD: Neoplastic meningitis in patients with adenocarcinoma of the gastrointestinal tract. Cancer; 2005 Jun 1;103(11):2355-62
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Neoplastic meningitis in patients with adenocarcinoma of the gastrointestinal tract.
  • RESULTS: The patient population was composed of patients with gastric adenocarcinoma (n = 8 patients), esophageal adenocarcinoma (n = 7 patients), colon and/or rectal adenocarcinoma (n = 5 patients), and pancreatic adenocarcinoma (n = 1 patient).
  • The median overall survival after the initial diagnosis of adenocarcinoma was 55 weeks (range, 8-884 wks), and the median survival after the diagnosis of NM was 7 weeks (range, 0-64 wks).
  • No factors identified had an impact on outcome, including symptoms, physical findings at diagnosis, imaging characteristics, or cerebrospinal fluid findings.
  • CONCLUSIONS: Patients with NM from GI tract adenocarcinomas universally had poor outcomes.
  • [MeSH-major] Adenocarcinoma / secondary. Gastrointestinal Neoplasms / pathology. Meningeal Neoplasms / secondary

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15856426.001).
  • [ISSN] 0008-543X
  • [Journal-full-title] Cancer
  • [ISO-abbreviation] Cancer
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't; Review
  • [Publication-country] United States
  • [Number-of-references] 39
  •  go-up   go-down


38. Ibáñez Aguirre FJ, Azagra JS, Erro Azcárate ML, Goergen M, Rico Selas P, Moreno Elola-Olaso A, Clemares de Lama M, de Simone P, Echenique Elizondo MM: Laparoscopic gastrectomy for gastric adenocarcinoma. Long-term results. Rev Esp Enferm Dig; 2006 Jul;98(7):491-500
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Laparoscopic gastrectomy for gastric adenocarcinoma. Long-term results.
  • BACKGROUND: The objective of our paper is to report on the long-term results of patients with gastric cancer treated by mini-invasive surgery with "intention-to-treat" laparoscopy.
  • PATIENTS AND METHODS: Between June 1993 and January 2006, 130 patients comprising 94 men and 36 women with gastric adenocarcinoma were prospectively selected by two surgical teams in three hospitals based on a prior agreement (CHU Charleroi, Belgium, Centre Hospitalier de Luxembourg and Zumárraga Hospital, Spain).
  • Patients with adenocarcinoma of the cardia were excluded.
  • CONCLUSIONS: Laparoscopic gastrectomy with any kind of lymphadenectomy is a major but safe operation with acceptable mortality and morbility rates in patients with advanced gastric cancer, usually in poor general condition.
  • [MeSH-major] Adenocarcinoma / surgery. Gastrectomy / methods. Laparoscopy. Stomach Neoplasms / surgery

  • MedlinePlus Health Information. consumer health - Stomach Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentIn] Rev Esp Enferm Dig. 2006 Jul;98(7):485-90 [17022697.001]
  • (PMID = 17022698.001).
  • [ISSN] 1130-0108
  • [Journal-full-title] Revista española de enfermedades digestivas : organo oficial de la Sociedad Española de Patología Digestiva
  • [ISO-abbreviation] Rev Esp Enferm Dig
  • [Language] eng; spa
  • [Publication-type] Journal Article
  • [Publication-country] Spain
  •  go-up   go-down


39. Chakrabarti N, Moulick A, Saha J, Dutta A: Splenic metastasis and bleeding manifestations--an unusual association with gastric malignancy. J Assoc Physicians India; 2008 Jul;56:543-4
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Splenic metastasis and bleeding manifestations--an unusual association with gastric malignancy.
  • We report the case of a 30 year old female who presented with purpura and melena and who was later diagnosed to have a mucinous adenocarcinoma of stomach with disseminated intravascular coagulation and splenic metastasis.
  • [MeSH-major] Adenocarcinoma, Mucinous / pathology. Disseminated Intravascular Coagulation / etiology. Splenic Neoplasms / secondary. Stomach Neoplasms / pathology

  • MedlinePlus Health Information. consumer health - Stomach Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18846909.001).
  • [ISSN] 0004-5772
  • [Journal-full-title] The Journal of the Association of Physicians of India
  • [ISO-abbreviation] J Assoc Physicians India
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] India
  •  go-up   go-down


40. Herrera-Goepfert R, Akiba S, Koriyama C, Ding S, Reyes E, Itoh T, Minakami Y, Eizuru Y: Epstein-Barr virus-associated gastric carcinoma: Evidence of age-dependence among a Mexican population. World J Gastroenterol; 2005 Oct 21;11(39):6096-103
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Epstein-Barr virus-associated gastric carcinoma: Evidence of age-dependence among a Mexican population.
  • AIM: To investigate features of Epstein-Barr virus (EBV)-associated gastric carcinoma (EBVaGC) among a Mexican population.
  • METHODS: Cases of primary gastric adenocarcinoma were retrieved from the files of the Departments of Pathology at the Instituto Nacional de Cancerologia and the Instituto Nacional de la Nutricion in Mexico City.
  • The anatomic site of the gastric neoplasia was identified, and carcinomas were histologically classified as intestinal and diffuse types and subclassified as proposed by the Japanese Research Society for Gastric Cancer.
  • RESULTS: We studied 330 consecutive, non-selected, primary gastric carcinomas.
  • The mean age for the entire group was 58.1 years (range: 20-88 years), whereas the mean age for patients harboring EBER-1-positive gastric carcinomas was 65.3 years (range: 50-84 years).
  • Age and histological type showed statistically significant differences, when EBER-1-positive and -negative gastric carcinomas were compared.
  • EBER-1 was detected in hyperplastic- and dysplastic-gastric mucosa surrounding two EBER-1-negative carcinomas, respectively.
  • [MeSH-major] Epstein-Barr Virus Infections / complications. Epstein-Barr Virus Infections / ethnology. Stomach Neoplasms / ethnology. Stomach Neoplasms / virology

  • MedlinePlus Health Information. consumer health - Stomach Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16273633.001).
  • [ISSN] 1007-9327
  • [Journal-full-title] World journal of gastroenterology
  • [ISO-abbreviation] World J. Gastroenterol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] China
  • [Other-IDs] NLM/ PMC4436624
  •  go-up   go-down


41. Yang W, Toffa SE, Lohn JW, Seifalian AM, Winslet MC: Malignant ascites increases the antioxidant ability of human ovarian (SKOV-3) and gastric adenocarcinoma (KATO-III) cells. Gynecol Oncol; 2005 Feb;96(2):430-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Malignant ascites increases the antioxidant ability of human ovarian (SKOV-3) and gastric adenocarcinoma (KATO-III) cells.
  • OBJECTIVES: The antioxidant status of cancer cells is an important factor in tumor invasion and metastases.
  • This study investigated whether metastatic cancer cells derive beneficial antioxidant protection from ascitic fluid and are rendered resistant to oxidative stress in the form of a chemically generated free radical insult.
  • METHODS: Human gastric carcinoma (KATO-III) and ovarian adenocarcinoma (SKOV-3) cell lines were cultured and incubated for 24 h with (1) M199 medium;.
  • CD44 gene expression of cancer cells was analyzed by Northern blotting.
  • RESULTS: The results showed that the cancer cells were rendered resistant to oxidative stress and with upregulated CD44 gene expression by components of malignant ascites.
  • CONCLUSIONS: These findings suggest that malignant ascites increases the antioxidant ability of cancer cells and the potential of adhesion and invasion.
  • [MeSH-major] Adenocarcinoma / metabolism. Antioxidants / metabolism. Ascites / metabolism. Ovarian Neoplasms / metabolism. Stomach Neoplasms / metabolism


42. Schmidt N, Peitz U, Lippert H, Malfertheiner P: Missing gastric cancer in dyspepsia. Aliment Pharmacol Ther; 2005 Apr 1;21(7):813-20
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Missing gastric cancer in dyspepsia.
  • BACKGROUND: Dyspepsia is common in gastric cancer, but also in many benign conditions.
  • AIM: To investigate whether criteria for endoscopy in patients with dyspepsia are adequate to detect gastric cancer.
  • METHODS: In 215 patients at initial diagnosis of gastric adenocarcinoma, symptoms were classified as alarm and non-alarm.
  • Only 53 potentially curable stages and 18 early gastric cancers occurred, but the tumour stage was not associated with dyspepsia duration, age threshold of 45 years, or alarm symptoms.
  • CONCLUSIONS: Our results support current European Helicobacter Study Group and American Gastroenterological Association criteria for endoscopy in patients with dyspepsia to detect gastric cancer.
  • [MeSH-major] Diagnostic Errors. Dyspepsia / etiology. Gastroscopy / standards. Stomach Neoplasms / diagnosis

  • Genetic Alliance. consumer health - Dyspepsia.
  • MedlinePlus Health Information. consumer health - Indigestion.
  • MedlinePlus Health Information. consumer health - Stomach Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15801916.001).
  • [ISSN] 0269-2813
  • [Journal-full-title] Alimentary pharmacology & therapeutics
  • [ISO-abbreviation] Aliment. Pharmacol. Ther.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  •  go-up   go-down


43. Kleikamp S, Böhm M, Frosch P, Brinkmeier T: [Acanthosis nigricans, papillomatosis mucosae and "tripe palms" in a patient with metastasized gastric carcinoma]. Dtsch Med Wochenschr; 2006 May 26;131(21):1209-13
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Acanthosis nigricans, papillomatosis mucosae and "tripe palms" in a patient with metastasized gastric carcinoma].
  • Gastroscopic findings were suspicious of adenocarcinoma of the stomach: it was classified histologically as a signet-ring cell, non-mucinous adenocarcinoma.
  • At the time of diagnosis the tumor had already metastasized to perigastric and peripancreatic lymph nodes with peritoneal carcinosis.
  • [MeSH-major] Carcinoma, Signet Ring Cell / diagnosis. Carcinoma, Signet Ring Cell / secondary. Skin Diseases / etiology. Stomach Neoplasms / diagnosis. Stomach Neoplasms / pathology
  • [MeSH-minor] Acanthosis Nigricans / diagnosis. Acanthosis Nigricans / etiology. Antigens, Tumor-Associated, Carbohydrate / blood. Biomarkers, Tumor / blood. CA-19-9 Antigen / blood. Carcinoembryonic Antigen / blood. Fatal Outcome. Humans. Immunohistochemistry. Keratoderma, Palmoplantar / diagnosis. Keratoderma, Palmoplantar / etiology. Lymphatic Metastasis. Male. Middle Aged. Mouth Neoplasms / diagnosis. Mouth Neoplasms / etiology. Obesity / complications. Papilloma / diagnosis. Papilloma / etiology. Peritoneal Neoplasms / secondary. Receptor, Melanocortin, Type 1 / analysis

  • Genetic Alliance. consumer health - Acanthosis Nigricans.
  • MedlinePlus Health Information. consumer health - Skin Conditions.
  • MedlinePlus Health Information. consumer health - Stomach Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16721709.001).
  • [ISSN] 0012-0472
  • [Journal-full-title] Deutsche medizinische Wochenschrift (1946)
  • [ISO-abbreviation] Dtsch. Med. Wochenschr.
  • [Language] ger
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / Antigens, Tumor-Associated, Carbohydrate; 0 / Biomarkers, Tumor; 0 / CA-19-9 Antigen; 0 / CA-72-4 antigen; 0 / Carcinoembryonic Antigen; 0 / Receptor, Melanocortin, Type 1
  •  go-up   go-down


44. Akahoshi K, Honda K, Akahane H, Akiba H, Matsui N, Motomura Y, Kubokawa M, Endo S, Higuchi N, Oya M: Endoscopic submucosal dissection by using a grasping-type scissors forceps: a preliminary clinical study (with video). Gastrointest Endosc; 2008 Jun;67(7):1128-33
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • OBJECTIVE: To evaluate the efficacy and safety of ESD by using GSF for the removal of gastric neoplasms in human beings.
  • PATIENTS: Four patients with early gastric neoplastic lesions.
  • [MeSH-major] Adenocarcinoma / surgery. Gastroscopes. Gastroscopy / methods. Stomach Neoplasms / surgery

  • MedlinePlus Health Information. consumer health - Stomach Cancer.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18355820.001).
  • [ISSN] 1097-6779
  • [Journal-full-title] Gastrointestinal endoscopy
  • [ISO-abbreviation] Gastrointest. Endosc.
  • [Language] eng
  • [Publication-type] Clinical Trial; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


45. Hall JD, Kahaleh M, White GE, Talreja J, Northup PG, Shami VM: Presence of lymph node vasculature: a new EUS criterion for benign nodes? Dig Dis Sci; 2009 Jan;54(1):118-21
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • CONCLUSIONS: The presence of intranodal vasculature was universally associated with a benign diagnosis.
  • [MeSH-minor] Adenocarcinoma / diagnostic imaging. Adenocarcinoma / pathology. Biopsy, Fine-Needle. Esophageal Neoplasms / diagnostic imaging. Esophageal Neoplasms / pathology. Female. Humans. Logistic Models. Male. Mediastinum. Middle Aged. Predictive Value of Tests. Prospective Studies. Risk Factors. Stomach Neoplasms / diagnostic imaging. Stomach Neoplasms / pathology

  • MedlinePlus Health Information. consumer health - Lymphatic Diseases.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentIn] Dig Dis Sci. 2009 Aug;54(8):1812-3 [19513832.001]
  • [Cites] Gastrointest Endosc. 1997 Jun;45(6):474-9 [9199903.001]
  • [Cites] Gastrointest Endosc. 1999 Sep;50(3):352-6 [10462655.001]
  • [Cites] Lung Cancer. 2004 Apr;44(1):53-60 [15013583.001]
  • [Cites] Radiology. 1998 Jul;208(1):117-23 [9646801.001]
  • [Cites] AJR Am J Roentgenol. 1990 Aug;155(2):277-81 [2115251.001]
  • [Cites] AJR Am J Roentgenol. 1997 May;168(5):1311-6 [9129432.001]
  • [Cites] Gastrointest Endosc. 2004 Feb;59(2):205-12 [14745393.001]
  • [Cites] Gastrointest Endosc. 2007 Apr;65(4):602-8 [17383457.001]
  • [Cites] Gastrointest Endosc. 2001 May;53(6):593-8 [11323584.001]
  • [Cites] Gastrointest Endosc. 1994 Jul-Aug;40(4):442-6 [7926534.001]
  • [Cites] Chest. 2003 Feb;123(2):442-51 [12576364.001]
  • (PMID = 18473175.001).
  • [ISSN] 1573-2568
  • [Journal-full-title] Digestive diseases and sciences
  • [ISO-abbreviation] Dig. Dis. Sci.
  • [Language] eng
  • [Grant] United States / NIDDK NIH HHS / DK / P30 DK067629
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


46. Li X, Yue ZC, Zhang YY, Bai J, Meng XN, Geng JS, Fu SB: Elevated serum level and gene polymorphisms of TGF-beta1 in gastric cancer. J Clin Lab Anal; 2008;22(3):164-71
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Elevated serum level and gene polymorphisms of TGF-beta1 in gastric cancer.
  • In this study, serum TGF-beta1 levels in gastric cancer (GC) patients and healthy volunteers were measured using enzyme-linked immunosorbent assay (ELISA).
  • Our evidence suggested that serum concentration of TGF-beta1 might be a novel tumor marker for GC and the polymorphisms of TGF-beta1 gene did not play a role as a determinant of serum TGF-beta1 concentration or as a genetic risk factor in the gastric carcinogenesis and progression.
  • [MeSH-major] Adenocarcinoma / blood. Genetic Predisposition to Disease. Polymorphism, Single Nucleotide / genetics. Stomach Neoplasms / blood. Transforming Growth Factor beta1 / blood

  • MedlinePlus Health Information. consumer health - Stomach Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] (c) 2008 Wiley-Liss, Inc.
  • (PMID = 18484655.001).
  • [ISSN] 0887-8013
  • [Journal-full-title] Journal of clinical laboratory analysis
  • [ISO-abbreviation] J. Clin. Lab. Anal.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / DNA, Neoplasm; 0 / Transforming Growth Factor beta1
  •  go-up   go-down


47. Elaraj DM, Ettinghausen SE: Cytological analysis of peritoneal washings: now part of the standard preoperative staging evaluation for patients with resectable gastric cancer? Ann Surg Oncol; 2005 May;12(5):339-41
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Cytological analysis of peritoneal washings: now part of the standard preoperative staging evaluation for patients with resectable gastric cancer?
  • [MeSH-major] Adenocarcinoma / surgery. Peritoneum / cytology. Stomach Neoplasms / pathology. Stomach Neoplasms / surgery

  • MedlinePlus Health Information. consumer health - Stomach Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentOn] Ann Surg Oncol. 2005 May;12(5):347-53 [15915368.001]
  • (PMID = 15843872.001).
  • [ISSN] 1068-9265
  • [Journal-full-title] Annals of surgical oncology
  • [ISO-abbreviation] Ann. Surg. Oncol.
  • [Language] eng
  • [Publication-type] Comment; Editorial
  • [Publication-country] United States
  •  go-up   go-down


48. Costantini R, De Nicola P, Bianco F, Cotroneo AR, Iezzi R, Di Bartolomeo N, Innocenti P: Tumor vs non-tumor origin of occult and obscure gastrointestinal bleeding requiring hospitalization. Tumori; 2007 Sep-Oct;93(5):461-6
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • RESULTS: Thirty-five cases of obscure and 27 cases of occult bleeding were examined; all received a definite diagnosis during hospitalization.
  • In the cases with obscure bleeding the diagnosis was inflammatory bowel disease (n = 7), angiodysplasia (5 gastric, 2 duodenal, 2 jejunal, 3 ileal, 4 right colon), small bowel tumors (4 non-Hodgkin lymphomas, 1 leiomyoma, 6 adenocarcinomas), and gastric metaplasia of Meckel's diverticulum (n = 1).
  • Intestinal resections were performed for all small bowel tumors (8 laparotomic, 3 laparoscopic), 5 angiodysplasias, all cases of inflammatory bowel disease and gastric metaplasia of Meckel's diverticulum; arterial embolization was performed for 11 angiodysplasias.
  • In the cases with occult bleeding the diagnosis was sigmoid colon polyps in 6 (treatment, endoscopic polypectomy) and right colon cancer in 21 (treatment, right hemicolectomy).
  • Thanks to modern technology, however, their diagnosis and treatment can nowadays be promptly and successfully achieved.
  • [MeSH-major] Gastrointestinal Hemorrhage / diagnosis. Intestinal Neoplasms / diagnosis. Occult Blood
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Capsules. Diagnosis, Differential. Endoscopy, Gastrointestinal. Female. Follow-Up Studies. Humans. Intestine, Small / pathology. Male. Middle Aged. Treatment Outcome. Videotape Recording

  • MedlinePlus Health Information. consumer health - Gastrointestinal Bleeding.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18038878.001).
  • [ISSN] 0300-8916
  • [Journal-full-title] Tumori
  • [ISO-abbreviation] Tumori
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Capsules
  •  go-up   go-down


49. Al-Taie OH, Adam P, Kraus MR, Illert B, Scheurlen M: Giant fold gastritis with consecutive gastric carcinoma in a patient with peutz-jeghers syndrome. Z Gastroenterol; 2005 Jul;43(7):653-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Giant fold gastritis with consecutive gastric carcinoma in a patient with peutz-jeghers syndrome.
  • We describe the case of a 36-year-old patient with Peutz-Jeghers syndrome and a very unusual gastric morphology resembling giant fold gastritis.
  • Endoscopic ultrasound documented a hyperechoic widening of the gastric mucosa without involvement of the deeper layers.
  • However, despite annual control gastroscopies, an adenocarcinoma developed between the folds and was in an already advanced stage at diagnosis (UICC III).
  • [MeSH-major] Adenocarcinoma / diagnosis. Gastritis, Hypertrophic / diagnosis. Peutz-Jeghers Syndrome / diagnosis. Stomach Neoplasms / diagnosis
  • [MeSH-minor] Adult. Cell Transformation, Neoplastic / pathology. Endosonography. Gastrectomy. Gastric Mucosa / pathology. Gastric Mucosa / surgery. Gastroscopy. Helicobacter Infections / diagnosis. Helicobacter Infections / pathology. Helicobacter pylori. Humans. Male. Neoplasm Staging. Predictive Value of Tests

  • Genetic Alliance. consumer health - Peutz Jeghers syndrome.
  • MedlinePlus Health Information. consumer health - Stomach Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16001347.001).
  • [ISSN] 0044-2771
  • [Journal-full-title] Zeitschrift für Gastroenterologie
  • [ISO-abbreviation] Z Gastroenterol
  • [Language] eng
  • [Publication-type] Case Reports; Comparative Study; Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


50. Komatsu S, Ichikawa D, Kurioka H, Koide K, Ueshima Y, Shioaki Y, Lee CJ, Mutoh F, Hosokawa Y, Oka T, Yamagishi H: Intra-abdominal desmoid tumor mimicking lymph node recurrence after gastrectomy for gastric cancer. J Gastroenterol Hepatol; 2006 Jul;21(7):1224-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Intra-abdominal desmoid tumor mimicking lymph node recurrence after gastrectomy for gastric cancer.
  • [MeSH-major] Abdominal Neoplasms / diagnosis. Adenocarcinoma / surgery. Fibromatosis, Aggressive / diagnosis. Gastrectomy. Neoplasm Recurrence, Local / diagnosis. Stomach Neoplasms / surgery
  • [MeSH-minor] Diagnosis, Differential. Follow-Up Studies. Humans. Lymphatic Metastasis. Magnetic Resonance Imaging. Male. Middle Aged. Tomography, X-Ray Computed

  • Genetic Alliance. consumer health - Desmoid Tumor.
  • MedlinePlus Health Information. consumer health - Stomach Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16824087.001).
  • [ISSN] 0815-9319
  • [Journal-full-title] Journal of gastroenterology and hepatology
  • [ISO-abbreviation] J. Gastroenterol. Hepatol.
  • [Language] eng
  • [Publication-type] Case Reports; Letter
  • [Publication-country] Australia
  •  go-up   go-down


51. Hayashi M, Inokuchi M, Takagi Y, Yamada H, Kojima K, Kumagai J, Kawano T, Sugihara K: High expression of HER3 is associated with a decreased survival in gastric cancer. Clin Cancer Res; 2008 Dec 1;14(23):7843-9
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] High expression of HER3 is associated with a decreased survival in gastric cancer.
  • BACKGROUND: The role of human epidermal growth factor receptor (HER) 3 and HER4 has been elucidated in gastric cancer.
  • This study investigated the positive correlation between HER1 and HER4 expression and the prognosis of patients with gastric cancers.
  • EXPERIMENTAL DESIGN: Tumor samples were obtained from gastric adenocarcinomas of 134 patients who underwent a gastrectomy from 1999 to 2002.
  • CONCLUSIONS: HER3 overexpression is strongly associated with tumor progression and poor prognosis of patients with gastric cancer.
  • [MeSH-major] Adenocarcinoma / metabolism. Adenocarcinoma / pathology. Receptor, ErbB-3 / biosynthesis. Stomach Neoplasms / metabolism. Stomach Neoplasms / pathology


52. Takagi T, Iio A, Nakagawa Y, Naoe T, Tanigawa N, Akao Y: Decreased expression of microRNA-143 and -145 in human gastric cancers. Oncology; 2009;77(1):12-21
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Decreased expression of microRNA-143 and -145 in human gastric cancers.
  • We investigated the role of the miRNAs miR-143 and miR-145 in gastric cancers.
  • METHODS: The expression levels of miR-143 and miR-145 in the samples from 43 patients with gastric cancer were determined by real-time PCR using TaqMan assay.
  • The growth inhibitory effect was estimated by the transfection of human gastric cancer cells with the miRNA.
  • RESULTS: The expression levels of miR-143 and -145 were decreased in most human gastric cancers examined, as previously reported to occur in colon tumors.
  • The transfection of human gastric MKN-1 cells with miR-145 resulted in a greater growth inhibitory effect than that with miR-143, results which were contrary to those in colon cancers.
  • [MeSH-major] Adenocarcinoma / genetics. Gene Expression Regulation, Neoplastic. MicroRNAs / physiology. Stomach Neoplasms / genetics

  • MedlinePlus Health Information. consumer health - Stomach Cancer.
  • Hazardous Substances Data Bank. FLUOROURACIL .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright 2009 S. Karger AG, Basel.
  • (PMID = 19439999.001).
  • [ISSN] 1423-0232
  • [Journal-full-title] Oncology
  • [ISO-abbreviation] Oncology
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Switzerland
  • [Chemical-registry-number] 0 / Antimetabolites, Antineoplastic; 0 / MIRN143 microRNA, human; 0 / MIRN145 microRNA, human; 0 / MicroRNAs; 0 / RNA, Messenger; U3P01618RT / Fluorouracil
  •  go-up   go-down


53. Stocker G, Ott K, Henningsen N, Becker K, Hapfelmeier A, Lordick F, Hois S, Plaschke S, Höfler H, Keller G: CyclinD1 and interleukin-1 receptor antagonist polymorphisms are associated with prognosis in neoadjuvant-treated gastric carcinoma. Eur J Cancer; 2009 Dec;45(18):3326-35
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] CyclinD1 and interleukin-1 receptor antagonist polymorphisms are associated with prognosis in neoadjuvant-treated gastric carcinoma.
  • PURPOSE: We evaluated DNA polymorphisms in genes related to DNA repair, cell-cycle control and tumour microenvironment to determine possible associations with response and survival in neoadjuvant-treated gastric cancer patients.
  • Significantly worse survival rates were noted in patients homozygous for the G-allele as compared to patients with the AG or AA genotypes of the cyclinD1 polymorphism (OS: P(log-rank) = 0.024; PFS: P(log-rank)=0.007) and in patients homozygous for the short allele compared to all other genotypes at the IL-1RN polymorphic locus (OS: P(log-rank) = 0.026; PFS: P(log-rank) = 0.013).
  • The combination of specific cyclinD1 and IL-1RN genotypes showed a particular prognostic relevance and should be considered an independent prognostic marker for neoadjuvant-treated gastric cancer patients.
  • [MeSH-major] Adenocarcinoma / genetics. Cyclin D1 / genetics. Interleukin 1 Receptor Antagonist Protein / genetics. Polymorphism, Single Nucleotide / genetics. Stomach Neoplasms / genetics

  • MedlinePlus Health Information. consumer health - Stomach Cancer.
  • Hazardous Substances Data Bank. CIS-DIAMINEDICHLOROPLATINUM .
  • Hazardous Substances Data Bank. FLUOROURACIL .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19822419.001).
  • [ISSN] 1879-0852
  • [Journal-full-title] European journal of cancer (Oxford, England : 1990)
  • [ISO-abbreviation] Eur. J. Cancer
  • [Language] eng
  • [Publication-type] Clinical Trial, Phase II; Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Antineoplastic Agents; 0 / Interleukin 1 Receptor Antagonist Protein; 136601-57-5 / Cyclin D1; Q20Q21Q62J / Cisplatin; U3P01618RT / Fluorouracil
  •  go-up   go-down


54. Haddad FS: Secondary adenocarcinomas of the urinary bladder. J Med Liban; 2008 Jan-Mar;56(1):48
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Secondary adenocarcinomas of the urinary bladder.
  • [MeSH-major] Adenocarcinoma / secondary. Prostatic Neoplasms / pathology. Stomach Neoplasms / pathology. Urinary Bladder Neoplasms / secondary
  • [MeSH-minor] Diagnosis, Differential. Humans. Male. Urinary Bladder / pathology

  • MedlinePlus Health Information. consumer health - Bladder Cancer.
  • MedlinePlus Health Information. consumer health - Prostate Cancer.
  • MedlinePlus Health Information. consumer health - Stomach Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentOn] J Med Liban. 2007 Jul-Sep;55(3):162-4 [17966739.001]
  • (PMID = 19534093.001).
  • [ISSN] 0023-9852
  • [Journal-full-title] Le Journal médical libanais. The Lebanese medical journal
  • [ISO-abbreviation] J Med Liban
  • [Language] eng
  • [Publication-type] Comment; Letter
  • [Publication-country] Lebanon
  •  go-up   go-down


55. Kanagavel D, Pokataev IA, Fedyanin MY, Tryakin AA, Bazin IS, Narimanov MN, Yakovleva ES, Garin AM, Tjulandin SA: A prognostic model in patients treated for metastatic gastric cancer with second-line chemotherapy. Ann Oncol; 2010 Sep;21(9):1779-85
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] A prognostic model in patients treated for metastatic gastric cancer with second-line chemotherapy.
  • BACKGROUND: This retrospective study was carried out to evaluate the prognostic significance of clinical factors in patients treated for metastatic gastric cancer with second-line chemotherapy.

  • Genetic Alliance. consumer health - Metastatic cancer.
  • MedlinePlus Health Information. consumer health - Liver Cancer.
  • MedlinePlus Health Information. consumer health - Ovarian Cancer.
  • MedlinePlus Health Information. consumer health - Stomach Cancer.
  • Hazardous Substances Data Bank. DOCETAXEL .
  • Hazardous Substances Data Bank. CIS-DIAMINEDICHLOROPLATINUM .
  • Hazardous Substances Data Bank. ETOPOSIDE .
  • Hazardous Substances Data Bank. MITOMYCIN C .
  • Hazardous Substances Data Bank. FLUOROURACIL .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20150573.001).
  • [ISSN] 1569-8041
  • [Journal-full-title] Annals of oncology : official journal of the European Society for Medical Oncology
  • [ISO-abbreviation] Ann. Oncol.
  • [Language] ENG
  • [Publication-type] Clinical Trial; Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Taxoids; 15H5577CQD / docetaxel; 50SG953SK6 / Mitomycin; 6PLQ3CP4P3 / Etoposide; Q20Q21Q62J / Cisplatin; U3P01618RT / Fluorouracil
  •  go-up   go-down


56. Lee MH, Kim SR, Soh JS, Chung MJ, Lee YC: A solitary gastric metastasis from pulmonary adenocarcinoma: a case report. Thorax; 2010 Jul;65(7):661-2
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] A solitary gastric metastasis from pulmonary adenocarcinoma: a case report.
  • [MeSH-major] Adenocarcinoma / secondary. Lung Neoplasms / diagnosis. Stomach Neoplasms / secondary

  • MedlinePlus Health Information. consumer health - Lung Cancer.
  • MedlinePlus Health Information. consumer health - Stomach Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20627930.001).
  • [ISSN] 1468-3296
  • [Journal-full-title] Thorax
  • [ISO-abbreviation] Thorax
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  •  go-up   go-down


57. de Mingo M, Morán A, Sánchez-Pernaute A, Iniesta P, Díez-Valladares L, Pérez-Aguirre E, de Juan C, García-Aranda C, Díaz-López A, García-Botella A, Martín-Antona E, Benito M, Torres A, Balibrea JL: Expression of MMP-9 and TIMP-1 as prognostic markers in gastric carcinoma. Hepatogastroenterology; 2007 Jan-Feb;54(73):315-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Expression of MMP-9 and TIMP-1 as prognostic markers in gastric carcinoma.
  • BACKGROUND/AIMS: The aim of the present work is to clarify the role of metalloproteinase-9 and its inhibitor in the evolution of gastric cancer after surgical resection.
  • METHODOLOGY: We have studied 44 gastric cancer patients submitted to surgery.
  • Metalloproteinase-9 and tissue inhibitor of metalloproteinase concentrations were investigated by means of ELISA in frozen samples of tumoral and normal gastric mucosa.
  • Cancer tissue also expressed higher levels of TIMP-1, 7.25 versus 4.39 ng/mg of protein.
  • CONCLUSIONS: The expression of metalloproteinase-9 or its inhibitor is related to a more aggressive phenotype of gastric cancer.
  • [MeSH-major] Adenocarcinoma / metabolism. Biomarkers, Tumor / metabolism. Matrix Metalloproteinase 9 / metabolism. Stomach Neoplasms / metabolism. Tissue Inhibitor of Metalloproteinase-1 / metabolism
  • [MeSH-minor] Aged. Enzyme-Linked Immunosorbent Assay. Female. Gastric Mucosa / metabolism. Humans. Male. Prognosis. Survival Analysis

  • MedlinePlus Health Information. consumer health - Stomach Cancer.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17419282.001).
  • [ISSN] 0172-6390
  • [Journal-full-title] Hepato-gastroenterology
  • [ISO-abbreviation] Hepatogastroenterology
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Greece
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / Tissue Inhibitor of Metalloproteinase-1; EC 3.4.24.35 / Matrix Metalloproteinase 9
  •  go-up   go-down


58. Trejo-de la O A, Torres J, Pérez-Rodríguez M, Camorlinga-Ponce M, Luna LF, Abdo-Francis JM, Lazcano E, Maldonado-Bernal C: TLR4 single-nucleotide polymorphisms alter mucosal cytokine and chemokine patterns in Mexican patients with Helicobacter pylori-associated gastroduodenal diseases. Clin Immunol; 2008 Nov;129(2):333-40
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Helicobacter pylori is associated with peptic ulcer and gastric adenocarcinoma.
  • We aimed to evaluate the association of TLR2/R753Q and TLR4/D299G/T399I SNPs with gastroduodenal diseases; and study the effect of SNPs on cytokine and chemokine expression in the gastric mucosa.
  • TLR4/D299G/T399I polymorphisms were more frequent in duodenal ulcer and showed a trend in gastric cancer, when compared with non-atrophic gastritis.
  • SNPs in TLR4 gene had an association with severe H. pylori-associated disease and with modified pattern of inflammatory cytokines and chemokines in the gastric mucosa.
  • [MeSH-major] Chemokines / analysis. Cytokines / analysis. Duodenal Ulcer / genetics. Gastritis / genetics. Helicobacter Infections / complications. Helicobacter pylori. Polymorphism, Single Nucleotide. Stomach Neoplasms / genetics. Toll-Like Receptor 2 / genetics. Toll-Like Receptor 4 / genetics

  • MedlinePlus Health Information. consumer health - Helicobacter Pylori Infections.
  • MedlinePlus Health Information. consumer health - Stomach Cancer.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18755634.001).
  • [ISSN] 1521-7035
  • [Journal-full-title] Clinical immunology (Orlando, Fla.)
  • [ISO-abbreviation] Clin. Immunol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Chemokines; 0 / Cytokines; 0 / TLR2 protein, human; 0 / TLR4 protein, human; 0 / Toll-Like Receptor 2; 0 / Toll-Like Receptor 4
  •  go-up   go-down


59. Jansen EP, Boot H, Dubbelman R, Verheij M, Cats A: Postoperative chemoradiotherapy in gastric cancer--a phase I-II study of radiotherapy with dose escalation of weekly cisplatin and daily capecitabine chemotherapy. Ann Oncol; 2010 Mar;21(3):530-4
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Postoperative chemoradiotherapy in gastric cancer--a phase I-II study of radiotherapy with dose escalation of weekly cisplatin and daily capecitabine chemotherapy.
  • BACKGROUND: Postoperative chemoradiotherapy with concurrent 5-fluorouracil improves gastric cancer outcome.
  • During chemoradiotherapy, seven patients developed 10 items of grade III and one episode of grade IV (mainly hematological) toxicity (National Cancer Institute-Common Toxicity Criteria version 3.0).
  • CONCLUSIONS: This phase I-II study demonstrated that postoperative chemoradiotherapy with weekly cisplatin and daily capecitabine is feasible in gastric cancer at the defined dose level.
  • This schedule is currently being tested as the experimental arm in a phase III multicenter study (CRITICS: chemoradiotherapy after induction chemotherapy in cancer of the stomach; Clinicaltrials.gov NCT 00407186).

  • MedlinePlus Health Information. consumer health - Stomach Cancer.
  • COS Scholar Universe. author profiles.
  • ClinicalTrials.gov. clinical trials - ClinicalTrials.gov .
  • Hazardous Substances Data Bank. CAPECITABINE .
  • Hazardous Substances Data Bank. CIS-DIAMINEDICHLOROPLATINUM .
  • Hazardous Substances Data Bank. FLUOROURACIL .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19690058.001).
  • [ISSN] 1569-8041
  • [Journal-full-title] Annals of oncology : official journal of the European Society for Medical Oncology
  • [ISO-abbreviation] Ann. Oncol.
  • [Language] ENG
  • [Databank-accession-numbers] ClinicalTrials.gov/ NCT00407186
  • [Publication-type] Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] 0W860991D6 / Deoxycytidine; 6804DJ8Z9U / Capecitabine; Q20Q21Q62J / Cisplatin; U3P01618RT / Fluorouracil
  •  go-up   go-down


60. Morishita Y, Kasakura Y, Kobayashi M, Mochizuki F, Yamagata M, Fujii M, Takayama T: Complete cure of metastatic gastric cancer treated with combination chemotherapy using S-1. Hepatogastroenterology; 2005 Nov-Dec;52(66):1933-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Complete cure of metastatic gastric cancer treated with combination chemotherapy using S-1.
  • A 65-year-old man had gastric cancer with liver and lung metastases, and received three cycles of FLEP (5-fluorouracil, leucovorin, etoposide, cisplatin) chemotherapy on June, 2001.
  • The primary lesion became scar ulceration and adenocarcinoma tissue was recognized by biopsy pathologically.
  • The clinical trial of S-1 as an adjuvant therapy for patients with advanced gastric cancer, who underwent curative resection, is ongoing in a multicenter study.
  • [MeSH-minor] Administration, Oral. Aged. Chemotherapy, Adjuvant. Cisplatin / administration & dosage. Dose-Response Relationship, Drug. Drug Administration Schedule. Epirubicin / administration & dosage. Fluorouracil / administration & dosage. Follow-Up Studies. Gastrectomy / methods. Humans. Leucovorin / administration & dosage. Male. Neoplasm Staging. Stomach Neoplasms / pathology. Stomach Neoplasms / surgery. Treatment Outcome

  • Genetic Alliance. consumer health - Metastatic cancer.
  • MedlinePlus Health Information. consumer health - Liver Cancer.
  • MedlinePlus Health Information. consumer health - Lung Cancer.
  • Hazardous Substances Data Bank. CIS-DIAMINEDICHLOROPLATINUM .
  • Hazardous Substances Data Bank. FLUOROURACIL .
  • Hazardous Substances Data Bank. EPIRUBICIN .
  • Hazardous Substances Data Bank. LEUCOVORIN .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16334810.001).
  • [ISSN] 0172-6390
  • [Journal-full-title] Hepato-gastroenterology
  • [ISO-abbreviation] Hepatogastroenterology
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Greece
  • [Chemical-registry-number] 3Z8479ZZ5X / Epirubicin; EC 1.3.1.2 / Dihydrouracil Dehydrogenase (NADP); Q20Q21Q62J / Cisplatin; Q573I9DVLP / Leucovorin; U3P01618RT / Fluorouracil; FLEP protocol
  •  go-up   go-down


61. Wang XP, Wang QX, Ying XP: Correlation between clinicopathology and expression of heat shock protein 72 and glycoprotein 96 in human gastric adenocarcinoma. Tohoku J Exp Med; 2007 May;212(1):35-41
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Correlation between clinicopathology and expression of heat shock protein 72 and glycoprotein 96 in human gastric adenocarcinoma.
  • Heat shock protein 72 (HSP72) and glycoprotein 96 (gp96) are highly expressed in cancer tissues.
  • Recent studies indicate the possible roles of HSP72 and gp96 in the development and progression of gastric carcinomas but detailed information is still ambiguous.
  • In this study, we investigated the correlation between clinicopathology and expression of HSP72 and gp96 in human gastric carcinoma.
  • The expression of HSP72 and gp96 was studied in 60 human gastric carcinomas with or without metastasis as well as in mucous membrane adjacent to cancers by way of immunohistochemistry.
  • Likewise, gp96 immunoreactivities were detected in 49 cases of gastric carcinoma (81.7%) and in 15 samples of mucous membrane adjacent to cancer (25.0%).
  • The results indicate that there exists a significant correlation between the expression of HSP72 and gp96 and the progression of gastric carcinomas.
  • The high-level expression of HSP72 and gp96 may be used as diagnostic or prognostic markers for gastric carcinoma.
  • [MeSH-major] Adenocarcinoma / pathology. Gene Expression. Glycoproteins / metabolism. HSP72 Heat-Shock Proteins / metabolism. Stomach Neoplasms / pathology
  • [MeSH-minor] Adult. Aged. Female. Gastric Mucosa / metabolism. Gastric Mucosa / pathology. Humans. Immunohistochemistry. Male. Middle Aged

  • MedlinePlus Health Information. consumer health - Stomach Cancer.
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17464101.001).
  • [ISSN] 0040-8727
  • [Journal-full-title] The Tohoku journal of experimental medicine
  • [ISO-abbreviation] Tohoku J. Exp. Med.
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] Japan
  • [Chemical-registry-number] 0 / Glycoproteins; 0 / HSP72 Heat-Shock Proteins
  •  go-up   go-down


62. Forte A, Leonetti G, Bosco M, Manfredelli S, De Sanctis R, Urbano V, Bezzi M: [The clinical significance of lymph node micrometastases and of concept of sentinel lymph node]. G Chir; 2006 Jun-Jul;27(6-7):277-80
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [MeSH-major] Lymph Nodes / pathology. Lymphatic Metastasis / diagnosis
  • [MeSH-minor] Adenocarcinoma / pathology. Aged. Colonic Neoplasms / pathology. Female. Humans. Immunohistochemistry. Lung Neoplasms / pathology. Male. Middle Aged. Neoplasm Staging. Prognosis. Sentinel Lymph Node Biopsy. Stomach Neoplasms / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17062200.001).
  • [ISSN] 0391-9005
  • [Journal-full-title] Il Giornale di chirurgia
  • [ISO-abbreviation] G Chir
  • [Language] ita
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Italy
  •  go-up   go-down


63. Jhawer M, Coit D, Brennan M, Qin LX, Gonen M, Klimstra D, Tang L, Kelsen DP, Shah MA: Perineural invasion after preoperative chemotherapy predicts poor survival in patients with locally advanced gastric cancer: gene expression analysis with pathologic validation. Am J Clin Oncol; 2009 Aug;32(4):356-62
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Perineural invasion after preoperative chemotherapy predicts poor survival in patients with locally advanced gastric cancer: gene expression analysis with pathologic validation.
  • BACKGROUND: We examined gene expression profiles and clinicopathologic features (tumor location, stage, graded pathologic response, perineural invasion (PNI), Lauren's classification, and survival) of patients with gastric cancer who received preoperative chemotherapy to identify prognostic markers.
  • METHODS: Thirty-eight patients with locally advanced gastric cancer received preoperative chemotherapy on a phase II trial.
  • The close association between PNI and overall survival was identified and validated immunohistochemically in 31 completely resected gastric tumors.
  • [MeSH-major] Adenocarcinoma / mortality. Adenocarcinoma / therapy. Peripheral Nervous System Neoplasms / mortality. Peripheral Nervous System Neoplasms / therapy. Stomach Neoplasms / mortality. Stomach Neoplasms / therapy

  • MedlinePlus Health Information. consumer health - Stomach Cancer.
  • COS Scholar Universe. author profiles.
  • Hazardous Substances Data Bank. CIS-DIAMINEDICHLOROPLATINUM .
  • Hazardous Substances Data Bank. FLUOROURACIL .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19381079.001).
  • [ISSN] 1537-453X
  • [Journal-full-title] American journal of clinical oncology
  • [ISO-abbreviation] Am. J. Clin. Oncol.
  • [Language] eng
  • [Grant] United States / NCI NIH HHS / CA / R01 CA56225
  • [Publication-type] Clinical Trial, Phase II; Comparative Study; Journal Article; Research Support, N.I.H., Extramural
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / RNA, Neoplasm; Q20Q21Q62J / Cisplatin; U3P01618RT / Fluorouracil
  •  go-up   go-down


64. Birbe R, Palazzo JP, Walters R, Weinberg D, Schulz S, Waldman SA: Guanylyl cyclase C is a marker of intestinal metaplasia, dysplasia, and adenocarcinoma of the gastrointestinal tract. Hum Pathol; 2005 Feb;36(2):170-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Guanylyl cyclase C is a marker of intestinal metaplasia, dysplasia, and adenocarcinoma of the gastrointestinal tract.
  • Gastrointestinal (GI) tumors continue to be major causes of cancer-related mortality, in part, reflecting metastases that escape detection by histopathology.
  • Guanylyl cyclase C (GC-C) is a receptor selectively expressed by intestinal epithelial cells whose persistent expression by colorectal carcinomas and ectopic expression by adenocarcinomas of the upper GI tract suggest its use as a marker for GI malignancies.
  • Guanylyl cyclase C protein was expressed by epithelial cells from the duodenum to the rectum, but not by those in normal esophagus and stomach.
  • Expression was retained in tubular adenomas, inflammatory bowel disease, premalignant lesions, and in primary and metastatic adenocarcinomas from the colon, including metastases to lymph nodes and liver.
  • Moreover, GC-C was ectopically expressed in all cases of dysplasia and adenocarcinomas arising from intestinal metaplasia in esophagus and stomach.
  • Thus, GC-C appears to be an immunohistochemical marker for identifying adenocarcinomas of unknown origin, metastases in patients undergoing staging for GI adenocarcinomas, and intestinal metaplasia, dysplasia, and tumors arising therein in the upper GI tract.
  • [MeSH-major] Adenocarcinoma / enzymology. Gastrointestinal Neoplasms / enzymology. Gastrointestinal Tract / enzymology. Guanylate Cyclase / metabolism. Metaplasia / enzymology. Receptors, Peptide / metabolism

  • COS Scholar Universe. author profiles.
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15754294.001).
  • [ISSN] 0046-8177
  • [Journal-full-title] Human pathology
  • [ISO-abbreviation] Hum. Pathol.
  • [Language] eng
  • [Grant] United States / NCI NIH HHS / CA / CA75123; United States / NCI NIH HHS / CA / CA79663; United States / NCI NIH HHS / CA / CA95026; United States / NCI NIH HHS / CA / R01 CA075123-06; United States / NIGMS NIH HHS / GM / R01 GM050290-05
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / RNA, Messenger; 0 / RNA, Neoplasm; 0 / Receptors, Peptide; EC 4.6.1.2 / Guanylate Cyclase; EC 4.6.1.2 / Receptors, Guanylate Cyclase-Coupled; EC 4.6.1.2 / enterotoxin receptor
  •  go-up   go-down


65. Liu T, Zhang G, Chen YH, Chen Y, Liu X, Peng J, Xu MH, Yuan JW: Tissue specific expression of suicide genes delivered by nanoparticles inhibits gastric carcinoma growth. Cancer Biol Ther; 2006 Dec;5(12):1683-90
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Tissue specific expression of suicide genes delivered by nanoparticles inhibits gastric carcinoma growth.
  • Developing an efficient and safe strategy to introduce a therapeutic gene into targeting cells in vivo is a key issue in cancer gene therapy nowadays.
  • Novel non-viral gene carriers, such as nanoparticles, have been shown to be able to deliver DNA into cancer cells efficiently.
  • Developing a targeting system for suicide gene is an attractive strategy in cancer gene therapy.
  • This construct was delivered into SGC7901 gastric cancer cells using calcium phosphate nanoparticles (CPNPs).
  • Immunofluorescence experiments showed that yCDglyTK is only expressed in CEA-positive cancer cells, but not in CEA-negative cells.
  • The expression of yCDglyTK induced cancer cell death following the addition of the prodrug 5-FC, and also elicit "bystander effect" to kill the neighboring cells.
  • Intratumoral injection of CPNP-yCDglyTK complex followed by administration of 5-FC produced marked regression in gastric cancer xenografts.
  • Taken together, our study suggests that the combination of calcium phosphate nanoparticles and suicide gene therapy represents a novel approach for targeting gastric cancer gene therapy.
  • [MeSH-major] Genes, Transgenic, Suicide / genetics. Genetic Therapy. Stomach Neoplasms / pathology
  • [MeSH-minor] Adenocarcinoma / genetics. Adenocarcinoma / prevention & control. Animals. Calcium Phosphates. Cell Division / genetics. Cell Line, Tumor. Cytomegalovirus / genetics. DNA, Neoplasm / genetics. HeLa Cells. Humans. Mice. Mice, Nude. Nanotechnology. Reverse Transcriptase Polymerase Chain Reaction. Transplantation, Heterologous

  • MedlinePlus Health Information. consumer health - Genes and Gene Therapy.
  • MedlinePlus Health Information. consumer health - Stomach Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentIn] Cancer Biol Ther. 2006 Dec;5(12):1691-2 [17224632.001]
  • (PMID = 17224635.001).
  • [ISSN] 1538-4047
  • [Journal-full-title] Cancer biology & therapy
  • [ISO-abbreviation] Cancer Biol. Ther.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Calcium Phosphates; 0 / DNA, Neoplasm
  •  go-up   go-down


66. Hirasawa T, Gotoda T, Miyata S, Kato Y, Shimoda T, Taniguchi H, Fujisaki J, Sano T, Yamaguchi T: Incidence of lymph node metastasis and the feasibility of endoscopic resection for undifferentiated-type early gastric cancer. Gastric Cancer; 2009;12(3):148-52
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Incidence of lymph node metastasis and the feasibility of endoscopic resection for undifferentiated-type early gastric cancer.
  • BACKGROUND: Endoscopic resection (ER) has been accepted as minimally invasive treatment in patients with early gastric cancer (EGC) who have a negligible risk of lymph node metastasis.
  • METHODS: We investigated 3843 patients who had undergone gastrectomy with lymph node dissection for solitary UD-type EGC at the Cancer Institute Hospital, Tokyo, and the National Cancer Center Hospital, Tokyo.
  • [MeSH-major] Adenocarcinoma / surgery. Gastric Mucosa / surgery. Gastroscopy / methods. Stomach Neoplasms / surgery


67. Ryan AM, Rowley SP, Fitzgerald AP, Ravi N, Reynolds JV: Adenocarcinoma of the oesophagus and gastric cardia: male preponderance in association with obesity. Eur J Cancer; 2006 May;42(8):1151-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Adenocarcinoma of the oesophagus and gastric cardia: male preponderance in association with obesity.
  • Recent evidence links obesity with the rising incidence of oesophageal adenocarcinoma.
  • In Ireland between 1995 and 2004 the incidence of oesophageal adenocarcinoma increased by 38%, and this coincided with a 67% increase in the prevalence of obesity.
  • In this study, a prospective case-control study was undertaken in 760 patients presenting to a tertiary centre between 1994 and 2004 diagnosed with cancer of the oesophagus, gastric cardia or stomach.
  • Multivariate logistic regression models were used to calculate the odds ratio (OR) of developing either cancer type according to quartiles of body mass index (BMI).
  • Based on pre-illness BMI, 82% of patients who developed adenocarcinoma of the oesophagus were either overweight or obese compared with 59% of the healthy control population (P<0.001).
  • A dose-dependent relationship existed between BMI and oesophageal adenocarcinoma in males.
  • Using common cut-off points for BMI, the OR of adenocarcinoma of the lower oesophagus was 11.3 times higher (95% CI: 3.5-36.4) for individuals with a BMI >30 kg/m2 versus individuals with a BMI <22 kg/m2 (P<0.001 for trend).
  • For adenocarcinoma of the gastric cardia, males in the top quartile of BMI had an OR of 3.5 (95% CI: 1.3-9.4) compared with the lowest quartile (P=0.03 for trend).
  • The odds ratio for adenocarcinoma of the oesophagus, the oesophago-gastric junction and gastric cardia rose significantly with increasing BMI.
  • [MeSH-major] Adenocarcinoma / etiology. Carcinoma, Squamous Cell / etiology. Cardia. Esophageal Neoplasms / etiology. Obesity / complications. Stomach Neoplasms / etiology


68. Cai JC, Liu D, Zhang HP, Zhong S, Xia NS: [Promoter methylation of several tumor suppressor genes in human gastric adenocarcinoma]. Zhonghua Yi Xue Za Zhi; 2007 Apr 10;87(14):978-81
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Promoter methylation of several tumor suppressor genes in human gastric adenocarcinoma].
  • OBJECTIVE: To study the promoter methylation of several tumor suppressor genes in human gastric foveolar epithelia (GFE) of chronic gastritis, adjacent GFE of gastric adenocarcinoma (GAC) and GAC.
  • METHODS: Methylation specific PCR (MSP) technique was used to examine the promoter methylation of 4 tumor suppressor genes (E-cadherin, hMLH1, APC, and MGMT) in 106 paraffin-embedded specimens of GAC, including tumor tissues and adjacent GFE, and 16 paraffin-embedded specimens of GFE of chronic gastritis.
  • Immunohistochemistry was used to detect the protein expression of E-cadherin (E-CD) in 46 out of the 106 cases of GAC.
  • RESULTS: The promoter methylation rates of tumor suppressor genes in the GAC tissue were 72.6% (77/106), significantly higher than that in the adjacent GFE (44.3%, 47/106) and the GFE of chronic gastritis (12.5%, 2/16, P < 0.01).
  • The promote methylation rate of tumor suppressor genes in the GAC Laurén diffuse type was 80.6% (50/62), significantly higher than that of the GAC of intestinal type (61.4%, 27/44, P < 0.01).
  • The rates of promoter methylation was significantly associated with depth of penetration, pTNM staging and degree of differentiation in GAC (all P < 0.05), but was no significantly associated with age, gender, Ming's classification and local lymph node metastasis (all P > 0.05).
  • The rate of loss of E-CD protein expression or heterogeneously reduction of E-CD protein expression in the specimens of GAC with promoter methylation was 90.9% (20/22), significantly higher than that in the specimens of GAC without promoter methylation (9/24, 37.5%, P < 0.01).
  • CONCLUSION: Promoter methylation of above tumor suppressor genes is seldom found in the GFE of chronic gastritis, frequently found in the adjacent GFE of GAC, but very commonly in GAC.
  • Promoter methylation may be an early event in the carcinogenesis of GAC.
  • [MeSH-major] Adenocarcinoma / genetics. DNA Methylation. Genes, Tumor Suppressor. Promoter Regions, Genetic. Stomach Neoplasms / genetics

  • MedlinePlus Health Information. consumer health - Stomach Cancer.
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17650424.001).
  • [ISSN] 0376-2491
  • [Journal-full-title] Zhonghua yi xue za zhi
  • [ISO-abbreviation] Zhonghua Yi Xue Za Zhi
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] China
  • [Chemical-registry-number] 0 / Adaptor Proteins, Signal Transducing; 0 / Adenomatous Polyposis Coli Protein; 0 / Cadherins; 0 / MLH1 protein, human; 0 / Nuclear Proteins; 0 / Tumor Suppressor Proteins; EC 2.1.1.- / DNA Modification Methylases; EC 2.1.1.63 / MGMT protein, human; EC 6.5.1.- / DNA Repair Enzymes
  •  go-up   go-down


69. Park DJ, Kong SH, Lee HJ, Kim WH, Yang HK, Lee KU, Choe KJ: Subclassification of pT2 gastric adenocarcinoma according to depth of invasion (pT2a vs pT2b) and lymph node status (pN). Surgery; 2007 Jun;141(6):757-63
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Subclassification of pT2 gastric adenocarcinoma according to depth of invasion (pT2a vs pT2b) and lymph node status (pN).
  • BACKGROUND: We investigated prognostic differences according to nodal status in patients with pT2a and pT2b stage gastric cancers.
  • METHODS: The clinicopathologic outcomes of 1118 patients who underwent curative resection and had 15 or more lymph nodes evaluated for pT2 stage gastric cancers between 1986 and 1996 were reviewed retrospectively.
  • Of the study group, 442 (39.5%) patients had pT2a stage gastric cancers and 676 (60.5%) had pT2b stage gastric cancers.
  • The prognosis of patients with pT2a gastric cancers was significantly better than that of patients with pT2b cancers on any pN stage (P < .001).
  • Multivariate analysis identified age, pT, and pN stages as independent prognostic factors for patients with pT2 gastric cancers.
  • CONCLUSIONS: The subclassification of pT2 gastric cancers into pT2a or pT2b is necessary to demonstrate their different prognoses.
  • We propose that the current stage grouping should be modified to better represent the prognosis for patients with stage pT2 gastric cancers.
  • [MeSH-major] Adenocarcinoma / classification. Adenocarcinoma / pathology. Lymph Nodes / pathology. Stomach Neoplasms / classification. Stomach Neoplasms / pathology

  • MedlinePlus Health Information. consumer health - Stomach Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17560252.001).
  • [ISSN] 0039-6060
  • [Journal-full-title] Surgery
  • [ISO-abbreviation] Surgery
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  •  go-up   go-down


70. Nakamura Y, Tanaka F, Nagahara H, Ieta K, Haraguchi N, Mimori K, Sasaki A, Inoue H, Yanaga K, Mori M: Opa interacting protein 5 (OIP5) is a novel cancer-testis specific gene in gastric cancer. Ann Surg Oncol; 2007 Feb;14(2):885-92
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Opa interacting protein 5 (OIP5) is a novel cancer-testis specific gene in gastric cancer.
  • BACKGROUND: Identification of novel cancer-specific antigens is important for the advancement of immunotherapy.
  • Our aim was to identify cancer-specific genes in gastric cancer.
  • METHODS: Using cDNA microarray analysis, we detected genes overexpressed specifically in gastric cancer cells.
  • We also compared the expression status of OIP5 with that of the other known cancer-testis specific genes.
  • RESULTS: Twenty-two genes were determined to be upregulated in gastric cancer cells.
  • Thus OIP5 may be considered a cancer-testis specific gene.
  • In 58 clinical cases of gastric cancer examined, we found OIP5 gene expression in 27 cases (47%).
  • Thirteen of these 27 cases showed no expression of the known cancer specific genes such as MAGE-1, MAGE-3 or NY-ESO-1.
  • CONCLUSIONS: Using a combination of LMD and microarray, we identified OIP5 as a cancer-testis specific gene.
  • Further expression analysis in a set of clinical cases revealed that OIP5 may be a novel immunotherapy target for patients with gastric cancer.
  • [MeSH-major] Adenocarcinoma / genetics. Antigens, Neoplasm / genetics. Exoribonucleases / genetics. Stomach Neoplasms / genetics

  • MedlinePlus Health Information. consumer health - Stomach Cancer.
  • COS Scholar Universe. author profiles.
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17151793.001).
  • [ISSN] 1068-9265
  • [Journal-full-title] Annals of surgical oncology
  • [ISO-abbreviation] Ann. Surg. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antigens, Neoplasm; 0 / Carrier Proteins; EC 3.1.- / Exoribonucleases
  •  go-up   go-down


71. Kim MS, Oh JE, Eom HS, Yoo NJ, Lee SH: Mutational analysis of UBR5 gene encoding an E3 ubiquitin ligase in common human cancers. Pathology; 2010 Jan;42(1):93-4
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [MeSH-major] Adenocarcinoma / genetics. Microsatellite Instability. Neoplasms / genetics. Polymorphism, Single-Stranded Conformational. Ubiquitin-Protein Ligases / genetics
  • [MeSH-minor] Breast Neoplasms / genetics. Breast Neoplasms / pathology. Carcinoma, Hepatocellular / genetics. Carcinoma, Hepatocellular / pathology. Colorectal Neoplasms / genetics. Colorectal Neoplasms / pathology. DNA Mutational Analysis. DNA, Neoplasm / analysis. Female. Humans. Leukemia / genetics. Leukemia / pathology. Liver Neoplasms / genetics. Liver Neoplasms / pathology. Lung Neoplasms / genetics. Lung Neoplasms / pathology. Stomach Neoplasms / genetics. Stomach Neoplasms / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20025491.001).
  • [ISSN] 1465-3931
  • [Journal-full-title] Pathology
  • [ISO-abbreviation] Pathology
  • [Language] eng
  • [Publication-type] Letter; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / DNA, Neoplasm; EC 6.3.2.- / UBR5 protein, human; EC 6.3.2.19 / Ubiquitin-Protein Ligases
  •  go-up   go-down


72. Ishikawa M, Kitayama J, Fujii S, Ishigami H, Kaizaki S, Nagawa H: Recurrent intramucosal gastric carcinoma with extensive invasion to duodenal mucosa after endoscopic mucosal resection: a case report. Am Surg; 2005 Apr;71(4):366-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Recurrent intramucosal gastric carcinoma with extensive invasion to duodenal mucosa after endoscopic mucosal resection: a case report.
  • The occurrence of early gastric carcinoma with invasion to the duodenum is supposed to be very low, although advanced cancers arising in the antrum can often invade the duodenal area.
  • Generally, malignant invasion of the duodenum is difficult to diagnose preoperatively, as spread of gastric cancer to the duodenum is often infiltrative and invades through the submucosal or subserosal layer.
  • We report an unusual case of an intramucosal gastric carcinoma with extensive duodenal invasion that was preoperatively diagnosed by endoscopy.
  • [MeSH-major] Adenocarcinoma / pathology. Duodenal Neoplasms / pathology. Endoscopy, Gastrointestinal. Stomach Neoplasms / pathology
  • [MeSH-minor] Aged. Biopsy. Follow-Up Studies. Gastrectomy. Gastric Mucosa / pathology. Humans. Laser Coagulation. Male. Neoplasm Invasiveness. Retrospective Studies

  • MedlinePlus Health Information. consumer health - Intestinal Cancer.
  • MedlinePlus Health Information. consumer health - Stomach Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15943416.001).
  • [ISSN] 0003-1348
  • [Journal-full-title] The American surgeon
  • [ISO-abbreviation] Am Surg
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


73. Yamashita H, Kitayama J, Ishigami H, Yamada J, Miyato H, Kaisaki S, Nagawa H: Endoscopic instillation of indigo carmine dye with acetic acid enables the visualization of distinct margin of superficial gastric lesion; Usefulness in endoscopic treatment and diagnosis of gastric cancer. Dig Liver Dis; 2007 Apr;39(4):389-91
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Endoscopic instillation of indigo carmine dye with acetic acid enables the visualization of distinct margin of superficial gastric lesion; Usefulness in endoscopic treatment and diagnosis of gastric cancer.
  • [MeSH-major] Acetic Acid. Adenocarcinoma / diagnosis. Coloring Agents. Gastroscopy. Indigo Carmine. Stomach Neoplasms / diagnosis
  • [MeSH-minor] Biopsy. Gastric Mucosa / pathology. Humans. Indicators and Reagents. Sensitivity and Specificity. Stomach / pathology

  • MedlinePlus Health Information. consumer health - Stomach Cancer.
  • Hazardous Substances Data Bank. INDIGO .
  • Hazardous Substances Data Bank. ACETIC ACID .
  • Hazardous Substances Data Bank. Indigotindisulfonate sodium .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17306635.001).
  • [ISSN] 1590-8658
  • [Journal-full-title] Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
  • [ISO-abbreviation] Dig Liver Dis
  • [Language] eng
  • [Publication-type] Letter
  • [Publication-country] Netherlands
  • [Chemical-registry-number] 0 / Coloring Agents; 0 / Indicators and Reagents; D3741U8K7L / Indigo Carmine; Q40Q9N063P / Acetic Acid
  •  go-up   go-down


74. Lima EM, Leal MF, Burbano RR, Khayat AS, Assumpção PP, Bello MJ, Rey JA, Smith MA, Casartelli C: Methylation status of ANAPC1, CDKN2A and TP53 promoter genes in individuals with gastric cancer. Braz J Med Biol Res; 2008 Jun;41(6):539-43
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Methylation status of ANAPC1, CDKN2A and TP53 promoter genes in individuals with gastric cancer.
  • Gastric cancer is the forth most frequent malignancy and the second most common cause of cancer death worldwide.
  • Many tumor genes are inactivated by DNA methylation in gastric cancer.
  • We evaluated the DNA methylation status of ANAPC1, CDKN2A and TP53 by methylation-specific PCR in 20 diffuse- and 26 intestinal-type gastric cancer samples and 20 normal gastric mucosa in individuals from Northern Brazil.
  • All gastric cancer samples were advanced stage adenocarcinomas.
  • Gastric samples were surgically obtained at the João de Barros Barreto University Hospital, State of Pará, and were stored at -80 degrees C before DNA extraction.
  • Patients had never been submitted to chemotherapy or radiotherapy, nor did they have any other diagnosed cancer.
  • None of the gastric cancer samples presented methylated DNA sequences for ANAPC1 and TP53.
  • CDKN2A methylation was not detected in any normal gastric mucosa; however, the CDKN2A promoter was methylated in 30.4% of gastric cancer samples, with 35% methylation in diffuse-type and 26.9% in intestinal-type cancers.
  • Thus, ANAPC1 and TP53 methylation was probably not implicated in gastric carcinogenesis in our samples.
  • CDKN2A can be implicated in the carcinogenesis process of only a subset of gastric neoplasias.

  • MedlinePlus Health Information. consumer health - Stomach Cancer.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18622497.001).
  • [ISSN] 1414-431X
  • [Journal-full-title] Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas
  • [ISO-abbreviation] Braz. J. Med. Biol. Res.
  • [Language] ENG
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Brazil
  • [Chemical-registry-number] 0 / ANAPC1 protein, human; 0 / Apc1 Subunit, Anaphase-Promoting Complex-Cyclosome; EC 6.3.2.19 / Anaphase-Promoting Complex-Cyclosome; EC 6.3.2.19 / Ubiquitin-Protein Ligase Complexes
  •  go-up   go-down


75. Alici S, Kaya S, Izmirli M, Tuncer I, Doğan E, Ozbek H, Sayarlioglu H: Analysis of survival factors in patients with advanced-stage gastric adenocarcinoma. Med Sci Monit; 2006 May;12(5):CR221-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Analysis of survival factors in patients with advanced-stage gastric adenocarcinoma.
  • BACKGROUND: Prognosis in patients with gastric cancer is determined by the tumor itself, as well as certain patient-related factors.
  • MATERIAL/METHODS: In this study, 138 patients with high-grade gastric adenocarcinoma who were admitted to our hospital between September 1999 and April 2002 were retrospectively evaluated in terms of the effects of clinicopathological parameters and treatment approaches on survival by single and multiple variable analyses.
  • Patients histopathologically diagnosed as having gastric adenocarcinomas with stage IV M0 (without distant organ metastasis) or stage IV M1, (with distant organ metastasis) were included in the study.
  • CONCLUSIONS: No surgical treatment, palliative surgery instead of radical surgery, and BMI below 20 on first admission were determined as poor prognostic factors related to survival in patients with high-grade gastric adenocarcinoma.
  • [MeSH-major] Adenocarcinoma / mortality. Stomach Neoplasms / mortality

  • MedlinePlus Health Information. consumer health - Stomach Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16641880.001).
  • [ISSN] 1234-1010
  • [Journal-full-title] Medical science monitor : international medical journal of experimental and clinical research
  • [ISO-abbreviation] Med. Sci. Monit.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Poland
  •  go-up   go-down


76. Gao JS, Wang ZJ, Wei GH, Song WL, Yi BQ, Gao ZG, Zhao B, Liu Z, Li A: Deep venous thrombosis after gastrectomy for gastric carcinoma: a case report. World J Gastroenterol; 2009 Feb 21;15(7):885-7
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Deep venous thrombosis after gastrectomy for gastric carcinoma: a case report.
  • The treatment of gastric carcinoma consists of neoadjuvant chemoradiation, partial gastrectomy, subtotal gastrectomy, total gastrectomy, extended resection, and postoperative chemotherapy.
  • Currently, gastrectomy and extended lymphadenectomy is the optimal choice for late gastric carcinoma.
  • However, deep venous thrombosis (DVT) is an uncommon complication after gastrectomy for gastric carcinoma.
  • We describe a case of a 68-year-old female patient with DVT after gastrectomy for gastric carcinoma.
  • We conclude that correct diagnosis and treatment of DVT are crucial.
  • [MeSH-major] Adenocarcinoma / surgery. Gastrectomy / adverse effects. Stomach Neoplasms / surgery. Venous Thrombosis / etiology

  • Genetic Alliance. consumer health - Thrombosis.
  • MedlinePlus Health Information. consumer health - Deep Vein Thrombosis.
  • MedlinePlus Health Information. consumer health - Stomach Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Ann Biol Clin (Paris). 2000 Nov-Dec;58(6):675-82 [11098164.001]
  • [Cites] Neoplasia. 2002 Nov-Dec;4(6):465-73 [12407439.001]
  • [Cites] Curr Opin Pulm Med. 2003 Sep;9(5):351-5 [12904702.001]
  • [Cites] S Afr J Surg. 2003 Aug;41(3):66-9 [14626890.001]
  • [Cites] Hematology Am Soc Hematol Educ Program. 2004;:439-56 [15561697.001]
  • [Cites] Vopr Onkol. 2007;53(6):722-3 [18416146.001]
  • [Cites] Eur J Surg Oncol. 2005 Nov;31(9):1036-8 [16154312.001]
  • [Cites] Hepatogastroenterology. 2006 Jan-Feb;53(67):145-9 [16506395.001]
  • [Cites] Vojnosanit Pregl. 2006 Mar;63(3):249-56 [16605190.001]
  • [Cites] Vnitr Lek. 2006 Mar;52 Suppl 1:127-8, 130-1 [16637461.001]
  • [Cites] Dig Dis Sci. 2007 Aug;52(8):1757-63 [17404848.001]
  • [Cites] Gastric Cancer. 2004;7(4):254-9 [15616774.001]
  • (PMID = 19230054.001).
  • [ISSN] 2219-2840
  • [Journal-full-title] World journal of gastroenterology
  • [ISO-abbreviation] World J. Gastroenterol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] China
  • [Chemical-registry-number] 0 / Anticoagulants; 0 / Heparin, Low-Molecular-Weight
  • [Other-IDs] NLM/ PMC2653393
  •  go-up   go-down


77. Nakamura H, Nakai S, Morifuji M, Fujimoto M, Miyamoto K, Yokoyama Y: [Combination of operation, chemotherapy and radiation for AFP producing gastric cancer--a case report]. Gan To Kagaku Ryoho; 2008 Feb;35(2):299-301
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Combination of operation, chemotherapy and radiation for AFP producing gastric cancer--a case report].
  • We report a case of AFP producing gastric cancer after a combination of operation, chemotherapy and radiation.
  • He was diagnosed as having type 3 advanced gastric cancer with multiple lymph node metastasis, including No. 8p lymph node, by endoscopy and computed tomography.
  • Histopathological study showed moderately differentiated adenocarcinoma, and immunohistochemical study revealed a few AFP-positive tumor cells.
  • [MeSH-major] Stomach Neoplasms / drug therapy. Stomach Neoplasms / radiotherapy. alpha-Fetoproteins / metabolism

  • MedlinePlus Health Information. consumer health - Stomach Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18281769.001).
  • [ISSN] 0385-0684
  • [Journal-full-title] Gan to kagaku ryoho. Cancer & chemotherapy
  • [ISO-abbreviation] Gan To Kagaku Ryoho
  • [Language] jpn
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Japan
  • [Chemical-registry-number] 0 / AFP protein, human; 0 / alpha-Fetoproteins
  •  go-up   go-down


78. Jin L, Yoshida M, Kitagawa Y, Saikawa Y, Takeuchi H, Wada N, Kumai K, Kubota T, Kitajima M: Subclassification of superficial cardia cancer in relation to the endoscopic esophagogastric junction. J Gastroenterol Hepatol; 2008 Dec;23 Suppl 2:S273-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Subclassification of superficial cardia cancer in relation to the endoscopic esophagogastric junction.
  • BACKGROUND: The incidence of adenocarcinoma of the gastric cardia has been reported to be increasing, but the endoscopic characteristics of the mucosal background of the tumor remain unclear.
  • The purpose of the present study was to evaluate the relationship between the location of the adenocarcinoma according to the esophagogastric junction (EGJ) and mucosal characteristics.
  • METHODS: Patients with superficial adenocarcinoma of the gastric cardia diagnosed pathologically were enrolled and divided into the above-EGJ group and the below-EGJ group according to tumor location.
  • CONCLUSION: There were significant differences between cancers above or below the EGJ, so classification of adenocarcinoma of the gastric cardia according to location is recommended.
  • [MeSH-major] Adenocarcinoma / pathology. Cardia / pathology. Endoscopy, Gastrointestinal. Esophagogastric Junction. Gastric Mucosa / pathology. Stomach Neoplasms / pathology
  • [MeSH-minor] Early Detection of Cancer. Esophagitis, Peptic / pathology. Gastritis, Atrophic / pathology. Hernia, Hiatal / pathology. Humans. Retrospective Studies

  • MedlinePlus Health Information. consumer health - Stomach Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19120911.001).
  • [ISSN] 1440-1746
  • [Journal-full-title] Journal of gastroenterology and hepatology
  • [ISO-abbreviation] J. Gastroenterol. Hepatol.
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] Australia
  •  go-up   go-down


79. Shutoh M, Oue N, Aung PP, Noguchi T, Kuraoka K, Nakayama H, Kawahara K, Yasui W: DNA methylation of genes linked with retinoid signaling in gastric carcinoma: expression of the retinoid acid receptor beta, cellular retinol-binding protein 1, and tazarotene-induced gene 1 genes is associated with DNA methylation. Cancer; 2005 Oct 15;104(8):1609-19
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] DNA methylation of genes linked with retinoid signaling in gastric carcinoma: expression of the retinoid acid receptor beta, cellular retinol-binding protein 1, and tazarotene-induced gene 1 genes is associated with DNA methylation.
  • To the authors' knowledge, little is known regarding the involvement of these three genes in gastric carcinoma (GC).
  • None of the 10 normal gastric mucosa samples from young, healthy individuals demonstrated hypermethylation of any of these genes.
  • CONCLUSIONS: The results suggested that gastric carcinogenesis involves transcriptional inactivation by aberrant DNA methylation of genes related to retinoid signaling.
  • [MeSH-major] DNA Methylation. Gene Expression Regulation, Neoplastic. Membrane Proteins / genetics. Receptors, Retinoic Acid / genetics. Retinoids / pharmacology. Retinol-Binding Proteins / genetics. Stomach Neoplasms / genetics
  • [MeSH-minor] Adenocarcinoma / genetics. Adenocarcinoma / pathology. Adult. Aged. Aged, 80 and over. Azacitidine / pharmacology. Carcinoma, Adenosquamous / genetics. Carcinoma, Adenosquamous / pathology. Female. Gastric Mucosa / metabolism. Gastric Mucosa / pathology. Gene Silencing. Genes, Tumor Suppressor. Humans. Intestinal Neoplasms / genetics. Intestinal Neoplasms / pathology. Male. Metaplasia / genetics. Metaplasia / pathology. Middle Aged. Promoter Regions, Genetic / genetics. RNA, Messenger / genetics. RNA, Messenger / metabolism. Retinol-Binding Proteins, Cellular. Reverse Transcriptase Polymerase Chain Reaction. Signal Transduction. Transcription, Genetic. Tumor Cells, Cultured

  • MedlinePlus Health Information. consumer health - Stomach Cancer.
  • Hazardous Substances Data Bank. AZACITIDINE .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright 2005 American Cancer Society
  • (PMID = 16134180.001).
  • [ISSN] 0008-543X
  • [Journal-full-title] Cancer
  • [ISO-abbreviation] Cancer
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Membrane Proteins; 0 / RARRES1 protein, human; 0 / RBP1 protein, human; 0 / RNA, Messenger; 0 / Receptors, Retinoic Acid; 0 / Retinoids; 0 / Retinol-Binding Proteins; 0 / Retinol-Binding Proteins, Cellular; 0 / retinoic acid receptor beta; M801H13NRU / Azacitidine
  •  go-up   go-down


80. Yonemura Y, Wu CC, Fukushima N, Honda I, Bandou E, Kawamura T, Kamata T, Kim BS, Matsuki N, Sawa T, Noh SH, East Asia Surgical Oncology Group: Randomized clinical trial of D2 and extended paraaortic lymphadenectomy in patients with gastric cancer. Int J Clin Oncol; 2008 Apr;13(2):132-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Randomized clinical trial of D2 and extended paraaortic lymphadenectomy in patients with gastric cancer.
  • BACKGROUND: The survival of patients with advanced gastric cancer after D2 dissection is still poor.
  • METHODS: Patients enrolled in the study had potentially curable gastric adenocarcinoma at an advanced stage.
  • Seven patients (5.2%) in the D2 and 15 (11.2%) in the D4 group died of causes other than gastric cancer recurrence.
  • CONCLUSION: Prophylactic D4 dissection is not recommended for patients with potentially curable advanced gastric cancer.
  • [MeSH-major] Adenocarcinoma / surgery. Gastrectomy / methods. Lymph Node Excision / methods. Stomach Neoplasms / surgery

  • MedlinePlus Health Information. consumer health - Stomach Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Clin Oncol. 2004 Jul 15;22(14):2767-73 [15199090.001]
  • [Cites] Lancet Oncol. 2006 Apr;7(4):309-15 [16574546.001]
  • [Cites] Lancet. 1996 Apr 13;347(9007):995-9 [8606613.001]
  • [Cites] Surg Today. 1994;24(6):488-93 [7919729.001]
  • [Cites] Surgery. 1998 May;123(5):573-8 [9591011.001]
  • [Cites] Lancet. 1995 Mar 25;345(8952):745-8 [7891484.001]
  • [Cites] J Clin Oncol. 2004 Jun 1;22(11):2069-77 [15082726.001]
  • [Cites] Jpn J Surg. 1981 Mar;11(2):127-39 [7300058.001]
  • [Cites] Minerva Chir. 2002 Oct;57(5):641-7 [12370665.001]
  • [Cites] Arch Surg. 1987 Nov;122(11):1347-51 [3675199.001]
  • [Cites] Gastric Cancer. 1999 Nov;2(3):179-185 [11957093.001]
  • [Cites] Hepatogastroenterology. 2006 May-Jun;53(69):389-94 [16795979.001]
  • [Cites] Gastric Cancer. 2004;7(4):196-201; discussion 201-203 [15616767.001]
  • [Cites] Hepatogastroenterology. 1999 Jul-Aug;46(28):2635-42 [10522056.001]
  • [Cites] Br J Surg. 2005 Jan;92(1):5-13 [15635680.001]
  • [Cites] J Thorac Cardiovasc Surg. 1997 Oct;114(4):544-51 [9338639.001]
  • [Cites] Br J Surg. 2004 Mar;91(3):283-7 [14991627.001]
  • (PMID = 18463957.001).
  • [ISSN] 1341-9625
  • [Journal-full-title] International journal of clinical oncology
  • [ISO-abbreviation] Int. J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article; Multicenter Study; Randomized Controlled Trial
  • [Publication-country] Japan
  •  go-up   go-down


81. Oh SC, Sur HY, Sung HJ, Choi IK, Park SS, Seo JH, Jeen YT, Chun HJ, Shin SW, Mok YJ, Kim JS, Kim YH: A phase II study of biweekly dose-intensified oral capecitabine plus irinotecan (bXELIRI) for patients with advanced or metastatic gastric cancer. Br J Cancer; 2007 May 21;96(10):1514-9
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] A phase II study of biweekly dose-intensified oral capecitabine plus irinotecan (bXELIRI) for patients with advanced or metastatic gastric cancer.
  • A previous study concluded that dose-intensified biweekly capecitabine seems to be more effective at increasing both response rate and progression-free survival time than conventional dose and schedule of capecitabine in colon cancer.
  • We conducted this study to ascertain the efficacy and toxicity of dose-intensified biweekly capecitabine and irinotecan combination chemotherapy in chemotherapy-naïve advanced or metastatic gastric cancer patients.
  • Biweekly dose-intensified capecitabine and irinotecan combination chemotherapy was active for the treatment of advanced or metastatic gastric cancers with a tolerable safety profile.
  • [MeSH-major] Adenocarcinoma / drug therapy. Antineoplastic Combined Chemotherapy Protocols / therapeutic use. Camptothecin / analogs & derivatives. Deoxycytidine / analogs & derivatives. Fluorouracil / analogs & derivatives. Stomach Neoplasms / drug therapy

  • Genetic Alliance. consumer health - Oral cancer.
  • Genetic Alliance. consumer health - Metastatic cancer.
  • MedlinePlus Health Information. consumer health - Stomach Cancer.
  • Hazardous Substances Data Bank. CAPECITABINE .
  • Hazardous Substances Data Bank. FLUOROURACIL .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Br J Cancer. 2005 Jul 25;93(2):190-4 [16012522.001]
  • [Cites] J Chemother. 2007 Feb;19(1):85-9 [17309856.001]
  • [Cites] J Clin Oncol. 2005 Aug 20;23(24):5660-7 [16110025.001]
  • [Cites] Cancer. 2005 Dec 15;104(12):2759-65 [16294344.001]
  • [Cites] J Natl Cancer Inst. 2000 Feb 2;92(3):205-16 [10655437.001]
  • [Cites] J Clin Oncol. 2000 Mar;18(6):1337-45 [10715306.001]
  • [Cites] Ann Oncol. 2002 Oct;13(10):1583-9 [12377646.001]
  • [Cites] Surg Oncol Clin N Am. 2002 Apr;11(2):235-56 [12424848.001]
  • [Cites] J Clin Oncol. 2002 Dec 1;20(23):4543-8 [12454110.001]
  • [Cites] J Clin Oncol. 2003 Apr 1;21(7):1307-12 [12663719.001]
  • [Cites] Oncology. 2003;64(3):232-6 [12697963.001]
  • [Cites] Clin Cancer Res. 2004 Feb 1;10(3):1121-9 [14871992.001]
  • [Cites] J Clin Oncol. 2004 Jun 1;22(11):2069-77 [15082726.001]
  • [Cites] Ann Oncol. 2004 Sep;15(9):1344-7 [15319239.001]
  • [Cites] Oncology. 2004;66(5):353-7 [15331921.001]
  • [Cites] Control Clin Trials. 1989 Mar;10(1):1-10 [2702835.001]
  • [Cites] CA Cancer J Clin. 1994 Jan-Feb;44(1):7-26 [8281473.001]
  • [Cites] Biochem Pharmacol. 1998 Mar 1;55(5):667-76 [9515577.001]
  • [Cites] Cancer. 1998 Apr 15;82(8):1460-7 [9554521.001]
  • [Cites] J Clin Oncol. 1998 May;16(5):1795-802 [9586893.001]
  • [Cites] J Clin Oncol. 1998 Sep;16(9):2977-85 [9738566.001]
  • [Cites] Cancer Chemother Pharmacol. 1998;42(5):391-9 [9771954.001]
  • [Cites] Ann Oncol. 2004 Dec;15(12):1773-81 [15550582.001]
  • [Cites] Clin Colorectal Cancer. 2005 Jan;4(5):336-43 [15663838.001]
  • [Cites] Ann Oncol. 2005 Feb;16(2):282-8 [15668285.001]
  • [Cites] Br J Cancer. 2005 May 9;92(9):1644-9 [15856038.001]
  • [Cites] Br J Cancer. 2005 Jun 6;92(11):1976-83 [15928658.001]
  • [Cites] Br J Cancer. 2005 Jun 20;92(12):2122-8 [15942629.001]
  • [Cites] Ann Oncol. 2005 Jul;16(7):1123-32 [15939714.001]
  • [Cites] Br J Cancer. 2006 May 8;94(9):1281-6 [16622464.001]
  • [Cites] J Clin Oncol. 2006 May 10;24(14):2137-50 [16682732.001]
  • [Cites] J Clin Oncol. 2006 May 10;24(14):2188-96 [16682738.001]
  • [Cites] Br J Cancer. 2006 May 22;94(10):1407-11 [16641916.001]
  • [Cites] J Clin Oncol. 2006 Jun 20;24(18):2903-9 [16782930.001]
  • [Cites] J Clin Oncol. 2006 Nov 1;24(31):4991-7 [17075117.001]
  • [Cites] Acta Oncol. 2005;44(3):230-5 [16076694.001]
  • (PMID = 17473829.001).
  • [ISSN] 0007-0920
  • [Journal-full-title] British journal of cancer
  • [ISO-abbreviation] Br. J. Cancer
  • [Language] eng
  • [Publication-type] Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0W860991D6 / Deoxycytidine; 6804DJ8Z9U / Capecitabine; 7673326042 / irinotecan; U3P01618RT / Fluorouracil; XT3Z54Z28A / Camptothecin; capecitabine-irinotecan combination
  • [Other-IDs] NLM/ PMC2359951
  •  go-up   go-down


82. Sasaki K, Natsugoe S, Aridome K, Ishigami S, Hokita S, Aikou T: The successfully curative treatment of advanced gastric adenocarcinoma with multiple liver metastases and paraaortic lymph node metastases by salvage operation following the biweekly paclitaxel and S-1 combination chemotherapy: a case report. Hepatogastroenterology; 2007 Dec;54(80):2421-4
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] The successfully curative treatment of advanced gastric adenocarcinoma with multiple liver metastases and paraaortic lymph node metastases by salvage operation following the biweekly paclitaxel and S-1 combination chemotherapy: a case report.
  • We report the case of 67-year-old man who was given a diagnosis of advanced gastric adenocarcinoma.
  • Biopsy of the liver was performed and the pathological diagnosis indicated no gastric adenocarcinoma cells.
  • The pathological report showed that the lymph node metastases had completely disappeared with single exception and minute cancerous lesions were identified in the gastric mucosa and submucosa.
  • Salvage surgery following paclitaxel and S-1 chemotherapy may be feasible for patients with advanced gastric cancer and complete regression of distant metastases.
  • Biweekly paclitaxel and S-1 combination chemotherapy has been used safely and its administration may be continued for a long time in an outpatient clinic setting for the treatment of advanced gastric cancer.
  • [MeSH-major] Adenocarcinoma / drug therapy. Adenocarcinoma / secondary. Antineoplastic Combined Chemotherapy Protocols / therapeutic use. Liver Neoplasms / secondary. Salvage Therapy. Stomach Neoplasms / drug therapy. Stomach Neoplasms / pathology

  • MedlinePlus Health Information. consumer health - Liver Cancer.
  • MedlinePlus Health Information. consumer health - Stomach Cancer.
  • Hazardous Substances Data Bank. TAXOL .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18265679.001).
  • [ISSN] 0172-6390
  • [Journal-full-title] Hepato-gastroenterology
  • [ISO-abbreviation] Hepatogastroenterology
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Greece
  • [Chemical-registry-number] 0 / Drug Combinations; 150863-82-4 / S 1 (combination); 1548R74NSZ / Tegafur; 5VT6420TIG / Oxonic Acid; P88XT4IS4D / Paclitaxel
  •  go-up   go-down


83. Wronski M, Ziarkiewicz-Wroblewska B, Gornicka B, Cebulski W, Slodkowski M, Wasiutynski A, Krasnodebski IW: Synchronous occurrence of gastrointestinal stromal tumors and other primary gastrointestinal neoplasms. World J Gastroenterol; 2006 Sep 7;12(33):5360-2
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The synchronous stromal tumors were located in the stomach and were incidentally found during the operation.
  • The coexistent neoplasms were colon adenocarcinoma, gastric cancer (2 cases) and gastric lymphoma.
  • [MeSH-major] Gastrointestinal Neoplasms / diagnosis. Gastrointestinal Stromal Tumors / diagnosis. Neoplasms, Second Primary / diagnosis

  • Genetic Alliance. consumer health - Gastrointestinal Stromal Tumors.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Arch Pathol Lab Med. 2000 May;124(5):682-6 [10782147.001]
  • [Cites] Hum Pathol. 2002 May;33(5):459-65 [12094370.001]
  • [Cites] J Gastroenterol Hepatol. 2002 Sep;17(9):1033-6 [12167128.001]
  • [Cites] Med Sci Monit. 2004 Aug;10(8):LE13-4 [15278004.001]
  • [Cites] World J Gastroenterol. 2006 Feb 7;12(5):815-7 [16521203.001]
  • [Cites] Cancer. 1984 Mar 1;53(5):1088-92 [6692300.001]
  • [Cites] Nat Genet. 1998 Aug;19(4):323-4 [9697690.001]
  • [Cites] Mayo Clin Proc. 1999 Jun;74(6):543-52 [10377927.001]
  • [Cites] Pol J Pathol. 2005;56(2):51-61 [16092666.001]
  • [Cites] Cancer Res. 1970 Feb;30(2):455-65 [5458974.001]
  • (PMID = 16981268.001).
  • [ISSN] 1007-9327
  • [Journal-full-title] World journal of gastroenterology
  • [ISO-abbreviation] World J. Gastroenterol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] China
  • [Chemical-registry-number] EC 2.7.10.1 / Proto-Oncogene Proteins c-kit
  • [Other-IDs] NLM/ PMC4088205
  •  go-up   go-down


84. Fukuda Y, Fujio N, Ihara T, Takatori H, Tsukazaki T, Koyama I, Tsukazaki Y, Osugi H: [A case of advanced gastric cancer with direct invasion of the transverse colon responding to paclitaxel/5'-DFUR combined therapy]. Gan To Kagaku Ryoho; 2005 Nov;32(12):1945-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [A case of advanced gastric cancer with direct invasion of the transverse colon responding to paclitaxel/5'-DFUR combined therapy].
  • A 50-year-old man was diagnosed with non-resectable scirrhous gastric cancer of antrum accompanied with colon ileus due to direct invasion of the transverse colon.
  • PTX/5'-DFUR therapy, which has only slight complications, may be useful for patients with recurrent gastric cancer who had been treated with 5-FU administration as first-line chemotherapy.
  • [MeSH-major] Adenocarcinoma, Scirrhous / drug therapy. Antineoplastic Combined Chemotherapy Protocols / therapeutic use. Colon, Transverse / pathology. Colonic Neoplasms / pathology. Stomach Neoplasms / drug therapy

  • MedlinePlus Health Information. consumer health - Stomach Cancer.
  • Hazardous Substances Data Bank. TAXOL .
  • Hazardous Substances Data Bank. FLOXURIDINE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16282732.001).
  • [ISSN] 0385-0684
  • [Journal-full-title] Gan to kagaku ryoho. Cancer & chemotherapy
  • [ISO-abbreviation] Gan To Kagaku Ryoho
  • [Language] jpn
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Japan
  • [Chemical-registry-number] 039LU44I5M / Floxuridine; P88XT4IS4D / Paclitaxel; V1JK16Y2JP / doxifluridine
  •  go-up   go-down


85. Kim YG, Jang BI, Kim TN: A matched case-control study of a novel Acid-pump antagonist and proton-pump inhibitor for the treatment of iatrogenic ulcers caused by endoscopic submucosal dissection. Gut Liver; 2010 Mar;4(1):25-30
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • METHODS: We reviewed the medical records of patients who underwent endoscopic submucosal dissection (ESD) for gastric neoplasia at Yeungnam University Hospital between January 2008 and May 2009.
  • In the revaprazan group, only one patient had stage H2 disease: a 54-year-old man with a 5.5-cm lesion after ESD of the ulcer, type IIa early gastric cancer, and adenocarcinoma.

  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Gut. 1992 May;33(5):617-21 [1319381.001]
  • [Cites] J Pharmacol Exp Ther. 2008 Jul;326(1):163-70 [18411413.001]
  • [Cites] Gastroenterology. 1992 Aug;103(2):407-13 [1634059.001]
  • [Cites] Gastroenterology. 1992 Feb;102(2):695-8 [1732139.001]
  • [Cites] Dig Dis Sci. 1988 May;33(5):619-24 [3282850.001]
  • [Cites] Biochem Pharmacol. 1995 Nov 9;50(10):1543-9 [7503755.001]
  • [Cites] Annu Rev Pharmacol Toxicol. 1995;35:277-305 [7598495.001]
  • [Cites] Dig Dis Sci. 1996 Oct;41(10):2039-47 [8888719.001]
  • [Cites] Free Radic Biol Med. 1996;21(5):727-31 [8891677.001]
  • [Cites] Pharmacotherapy. 1997 Jan-Feb;17(1):22-37 [9017763.001]
  • [Cites] J Clin Biochem Nutr. 2008 May;42(3):191-6 [18545640.001]
  • [Cites] Dig Dis Sci. 2009 Jul;54(7):1494-9 [19005762.001]
  • [Cites] Am J Gastroenterol. 2009 May;104(5):1130-4 [19337238.001]
  • [Cites] Aliment Pharmacol Ther. 2000 Apr;14 Suppl 1:74-81 [10807407.001]
  • [Cites] Am J Physiol Gastrointest Liver Physiol. 2001 Dec;281(6):G1502-11 [11705756.001]
  • [Cites] J Clin Pharmacol. 2004 Jan;44(1):73-82 [14681344.001]
  • [Cites] Wound Repair Regen. 2004 Jan-Feb;12(1):93-9 [14974970.001]
  • [Cites] Gastrointest Endosc. 2004 Aug;60(2):213-7 [15278047.001]
  • [Cites] Hum Mol Genet. 2004 Nov 15;13(22):2813-21 [15385447.001]
  • [Cites] Chin J Dig Dis. 2005;6(3):119-21 [16045601.001]
  • [Cites] J Gastroenterol. 2005 Jul;40(7):685-9 [16082584.001]
  • [Cites] J Biol Chem. 2006 Aug 18;281(33):23740-7 [16754665.001]
  • [Cites] J Med Invest. 2007 Feb;54(1-2):83-90 [17380018.001]
  • [Cites] Am J Physiol. 1992 Jun;262(6 Pt 2):H1955-8 [1320341.001]
  • (PMID = 20479909.001).
  • [ISSN] 2005-1212
  • [Journal-full-title] Gut and liver
  • [ISO-abbreviation] Gut Liver
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Korea (South)
  • [Other-IDs] NLM/ PMC2871596
  • [Keywords] NOTNLM ; Acid pump antagonists / Endoscopic submucosal dissection / Proton pump inhibitors / Rabeprazole / Revaprazan
  •  go-up   go-down


86. Zhou CJ, Liu B, Zhu KX, Zhang QH, Zhang TG, Xu WH, Wang HB, Yu WH, Qu YD, Wang HJ, Wu HL, Sun SZ, Guo JQ: The different expression of carcinoembryonic antigen-related cell adhesion molecule 1 (CEACAM1) and possible roles in gastric carcinomas. Pathol Res Pract; 2009;205(7):483-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] The different expression of carcinoembryonic antigen-related cell adhesion molecule 1 (CEACAM1) and possible roles in gastric carcinomas.
  • The purpose of this study was to investigate the expression of carcinoembryonic antigen-related cell adhesion molecule 1 (CEACAM1) and its effects on promoting angiogenesis in gastric adenocarcinomas.
  • Paraffin wax sections of 222 patients with gastric adenocarcinomas having undergone surgery between 2001 and 2006 were classified into three histotypes: intestinal, diffuse, and mixed carcinomas following the Laurén classification.
  • However, all of the collected gastric carcinomas expressed CEACAM1 with cytoplasmic or membranous staining.
  • [MeSH-major] Adenocarcinoma / immunology. Antigens, CD / analysis. Cell Adhesion Molecules / analysis. Gastric Mucosa / immunology. Stomach Neoplasms / immunology

  • MedlinePlus Health Information. consumer health - Stomach Cancer.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19243897.001).
  • [ISSN] 1618-0631
  • [Journal-full-title] Pathology, research and practice
  • [ISO-abbreviation] Pathol. Res. Pract.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / Antigens, CD; 0 / Antigens, CD31; 0 / CD66 antigens; 0 / Cell Adhesion Molecules
  •  go-up   go-down


87. Dipetrillo T, Milas L, Evans D, Akerman P, Ng T, Miner T, Cruff D, Chauhan B, Iannitti D, Harrington D, Safran H: Paclitaxel poliglumex (PPX-Xyotax) and concurrent radiation for esophageal and gastric cancer: a phase I study. Am J Clin Oncol; 2006 Aug;29(4):376-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Paclitaxel poliglumex (PPX-Xyotax) and concurrent radiation for esophageal and gastric cancer: a phase I study.
  • OBJECTIVES: To determine the maximal tolerated dose (MTD) and dose limiting toxicities of poly(l-glutamic acid)-paclitaxel (PPX) and concurrent radiation (PPX/RT) for patients with esophageal and gastric cancer.
  • METHODS: Patients with esophageal or gastric cancer receiving chemoradiation for loco-regional, adjuvant, or palliative intent were eligible.
  • Sixteen patients had esophageal cancer and 5 had gastric cancer.
  • CONCLUSIONS: The maximally tolerated dose of PPX with concurrent radiotherapy is 70 mg/m2/wk for patients with esophageal and gastric cancer.
  • [MeSH-major] Antineoplastic Agents / therapeutic use. Esophageal Neoplasms / drug therapy. Esophageal Neoplasms / radiotherapy. Paclitaxel / analogs & derivatives. Polyglutamic Acid / analogs & derivatives. Radiation-Sensitizing Agents / therapeutic use. Stomach Neoplasms / drug therapy. Stomach Neoplasms / radiotherapy
  • [MeSH-minor] Adenocarcinoma / drug therapy. Adenocarcinoma / radiotherapy. Adult. Aged. Aged, 80 and over. Carcinoma, Squamous Cell / drug therapy. Carcinoma, Squamous Cell / radiotherapy. Combined Modality Therapy. Female. Humans. Male. Maximum Tolerated Dose. Middle Aged. Radiotherapy, Conformal

  • Genetic Alliance. consumer health - Esophageal Cancer.
  • MedlinePlus Health Information. consumer health - Cancer Chemotherapy.
  • MedlinePlus Health Information. consumer health - Esophageal Cancer.
  • MedlinePlus Health Information. consumer health - Stomach Cancer.
  • Hazardous Substances Data Bank. TAXOL .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16891865.001).
  • [ISSN] 1537-453X
  • [Journal-full-title] American journal of clinical oncology
  • [ISO-abbreviation] Am. J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Clinical Trial, Phase I; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antineoplastic Agents; 0 / Radiation-Sensitizing Agents; 0 / paclitaxel poliglumex; 25513-46-6 / Polyglutamic Acid; P88XT4IS4D / Paclitaxel
  •  go-up   go-down


88. Hou Q, Wu YH, Grabsch H, Zhu Y, Leong SH, Ganesan K, Cross D, Tan LK, Tao J, Gopalakrishnan V, Tang BL, Kon OL, Tan P: Integrative genomics identifies RAB23 as an invasion mediator gene in diffuse-type gastric cancer. Cancer Res; 2008 Jun 15;68(12):4623-30
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Integrative genomics identifies RAB23 as an invasion mediator gene in diffuse-type gastric cancer.
  • Recurrent genomic amplifications and deletions are frequently observed in primary gastric cancers (GC).
  • RAB23 amplifications in primary gastric tumors were confirmed by both fluorescence in situ hybridization and genomic qPCR, and in two independent patient cohorts from Hong Kong and the United Kingdom RAB23 expression was significantly associated with diffuse-type GC (dGC) compared with intestinal-type GC (iGC).
  • These results provide further evidence that dGC and iGC likely represent two molecularly distinct tumor types, and show that investigating focal chromosomal amplifications by combining high-resolution aCGH with expression profiling is a powerful strategy for identifying novel cancer genes in regions of recurrent chromosomal aberration.
  • [MeSH-major] Chromosomes, Human, Pair 6 / genetics. Polymorphism, Single Nucleotide / genetics. Stomach Neoplasms / genetics. Stomach Neoplasms / pathology. rab GTP-Binding Proteins / genetics
  • [MeSH-minor] Adenocarcinoma / genetics. Adenocarcinoma / metabolism. Adenocarcinoma / secondary. Adult. Aged. Aged, 80 and over. Blotting, Western. Cell Movement. Chromosome Mapping. Chromosomes, Artificial, Bacterial. Cohort Studies. Female. Gene Amplification. Gene Dosage. Gene Expression Profiling. Gene Expression Regulation, Neoplastic. Genomics. Humans. Immunoenzyme Techniques. In Situ Hybridization, Fluorescence. Male. Middle Aged. Neoplasm Invasiveness. Oligonucleotide Array Sequence Analysis. RNA, Messenger / genetics. RNA, Messenger / metabolism. RNA, Small Interfering / pharmacology. Reverse Transcriptase Polymerase Chain Reaction. Tissue Array Analysis. Tumor Cells, Cultured

  • Genetic Alliance. consumer health - Signet ring cell carcinoma.
  • MedlinePlus Health Information. consumer health - Stomach Cancer.
  • COS Scholar Universe. author profiles.
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18559507.001).
  • [ISSN] 1538-7445
  • [Journal-full-title] Cancer research
  • [ISO-abbreviation] Cancer Res.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / RNA, Messenger; 0 / RNA, Small Interfering; EC 3.6.1.- / RAB23 protein, human; EC 3.6.1.- / rab GTP-Binding Proteins
  •  go-up   go-down


89. Song SY, Son HJ, Kim MH, Nam ES, Rhee JC, Park C: Prognostic significance of maspin expression in human gastric adenocarcinoma. Hepatogastroenterology; 2007 Apr-May;54(75):973-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Prognostic significance of maspin expression in human gastric adenocarcinoma.
  • However, molecular aspects in carcinogenesis and progression of gastric cancer remain largely unclear.
  • Previously we reported for the first time that maspin is induced in the course of gastric carcinogenesis.
  • In the present study we evaluated maspin induction in gastric adenocarcinoma in relation to a number of clinicopathologic feature.
  • METHODOLOGY: Maspin expression was examined by Western blot analysis and immunohistochemical staining in 82 cases of gastric adenocarcinoma.
  • RESULTS: In Western blot analysis, gastric specimens of tumor showed increased maspin expression compared with corresponding normal tissues in 54 of 82 patients (66%).
  • The frequency of maspin induction was associated with the stage of gastric cancer (p = 0.01) and lymph node metastasis (p = 0.03).
  • CONCLUSIONS: Our data suggest that maspin may have an important role in the progression and metastasis of gastric adenocarcinoma.
  • [MeSH-major] Adenocarcinoma / diagnosis. Serpins / analysis. Serpins / metabolism. Stomach Neoplasms / diagnosis
  • [MeSH-minor] Blotting, Western. Female. Helicobacter Infections / diagnosis. Humans. Immunohistochemistry. Male. Middle Aged. Prognosis. Up-Regulation

  • MedlinePlus Health Information. consumer health - Stomach Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17591106.001).
  • [ISSN] 0172-6390
  • [Journal-full-title] Hepato-gastroenterology
  • [ISO-abbreviation] Hepatogastroenterology
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Greece
  • [Chemical-registry-number] 0 / SERPIN-B5; 0 / Serpins
  •  go-up   go-down


90. Yu W, Choi GS, Chung HY: Randomized clinical trial of splenectomy versus splenic preservation in patients with proximal gastric cancer. Br J Surg; 2006 May;93(5):559-63
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Randomized clinical trial of splenectomy versus splenic preservation in patients with proximal gastric cancer.
  • BACKGROUND: Preservation or removal of the spleen during total gastrectomy for proximal gastric cancer is a matter of debate.
  • METHODS: A randomized clinical trial included patients with gastric adenocarcinoma who underwent total gastrectomy either with (104 patients) or without (103) splenectomy.
  • CONCLUSION: These results do not support the use of prophylactic splenectomy to remove macroscopically negative lymph nodes near the spleen in patients undergoing total gastrectomy for proximal gastric cancer.
  • [MeSH-major] Adenocarcinoma / surgery. Gastrectomy / methods. Spleen. Splenectomy. Stomach Neoplasms / surgery

  • MedlinePlus Health Information. consumer health - Stomach Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16607678.001).
  • [ISSN] 0007-1323
  • [Journal-full-title] The British journal of surgery
  • [ISO-abbreviation] Br J Surg
  • [Language] eng
  • [Publication-type] Journal Article; Randomized Controlled Trial
  • [Publication-country] England
  •  go-up   go-down


91. D'Hondt M, Van Rooy F, Devriendt D, Vansteenkiste F, Vanhauwaert H: Laparoscopic solution for early gastric cancer in a morbidly obese patient. Obes Surg; 2007 Mar;17(3):420-2
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Laparoscopic solution for early gastric cancer in a morbidly obese patient.
  • During preoperative work-up for laparoscopic gastric bypass in a morbidly obese female, gastroscopy visualized two small ulcers in the antrum.
  • Biopsies diagnosed adenocarcinoma of the diffuse type.
  • Staging was performed, and endoscopic ultrasonography showed early gastric cancer.
  • A laparoscopic neartotal gastrectomy with D1 resection and perigastric lymph node dissection and full omentectomy in combination with a gastric bypass, was peformed.
  • [MeSH-major] Adenocarcinoma / epidemiology. Adenocarcinoma / surgery. Gastrectomy. Obesity, Morbid / epidemiology. Stomach Neoplasms / epidemiology. Stomach Neoplasms / surgery

  • MedlinePlus Health Information. consumer health - Stomach Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Am Surg. 2004 Aug;70(8):684-6 [15328800.001]
  • [Cites] J Natl Cancer Inst. 1998 Jan 21;90(2):150-5 [9450576.001]
  • [Cites] J Natl Med Assoc. 2004 Jan;96(1):61-75 [14746355.001]
  • [Cites] Endoscopy. 2005 Jun;37(6):566-9 [15933931.001]
  • [Cites] J Surg Oncol. 1997 Jan;64(1):42-7 [9040800.001]
  • [Cites] South Med J. 1985 Mar;78(3):255-8 [3975734.001]
  • [Cites] Cancer Epidemiol Biomarkers Prev. 1995 Mar;4(2):85-92 [7742727.001]
  • [Cites] Obes Surg. 2002 Oct;12(5):634-8 [12448383.001]
  • [Cites] Obes Surg. 2005 Mar;15(3):423-7 [15826480.001]
  • [Cites] Obes Surg. 2006 Aug;16(8):1109-11 [16901371.001]
  • [Cites] Int J Cancer. 2006 May 15;118(10):2628-31 [16353151.001]
  • [Cites] World J Gastroenterol. 2006 Jan 21;12(3):354-62 [16489633.001]
  • [Cites] Ann Surg. 1999 Aug;230(2):170-8 [10450730.001]
  • [Cites] Aust N Z J Surg. 1997 Aug;67(8):580-2 [9287934.001]
  • [Cites] Obes Surg. 2005 Sep;15(8):1215-7 [16197800.001]
  • [Cites] Obes Surg. 2006 Feb;16(2):142-6 [16469214.001]
  • [Cites] Surg Endosc. 2004 Aug;18(8):1253-6 [15457385.001]
  • [Cites] Curr Surg. 2003 Sep-Oct;60(5):521-3 [14972217.001]
  • [Cites] Obes Surg. 2005 Sep;15(8):1171-6 [16197792.001]
  • [Cites] Ann Surg. 1989 Feb;209(2):162-6 [2644898.001]
  • (PMID = 17546855.001).
  • [ISSN] 0960-8923
  • [Journal-full-title] Obesity surgery
  • [ISO-abbreviation] Obes Surg
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


92. Lu CC, De-Chuan C, Lee HS, Chu HC: Pure hepatoid adenocarcinoma of the stomach with spleen and lymph-node metastases. Am J Surg; 2010 Apr;199(4):e42-4
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Pure hepatoid adenocarcinoma of the stomach with spleen and lymph-node metastases.
  • The authors report a rare case of hepatoid adenocarcinoma of the stomach, presenting initially with spleen and lymph node metastases.
  • [MeSH-major] Adenocarcinoma / diagnosis. Cardia. Liver Neoplasms / diagnosis. Lymph Nodes / pathology. Splenic Neoplasms / diagnosis. Stomach Neoplasms / diagnosis

  • MedlinePlus Health Information. consumer health - Liver Cancer.
  • MedlinePlus Health Information. consumer health - Stomach Cancer.
  • Hazardous Substances Data Bank. DOXORUBICIN .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright 2010 Elsevier Inc. All rights reserved.
  • (PMID = 20359564.001).
  • [ISSN] 1879-1883
  • [Journal-full-title] American journal of surgery
  • [ISO-abbreviation] Am. J. Surg.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / alpha-Fetoproteins; 8001-40-9 / Iodized Oil; 80168379AG / Doxorubicin
  •  go-up   go-down


93. Nunobe S, Gotoda T, Oda I, Katai H, Sano T, Shimoda T, Sasako M: Distribution of the deepest penetrating point of minute submucosal gastric cancer. Jpn J Clin Oncol; 2005 Oct;35(10):587-90
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Distribution of the deepest penetrating point of minute submucosal gastric cancer.
  • BACKGROUND: Accurate assessment of depth of invasion is critical in decision-making for additional surgery after endoscopic resection of early gastric cancer (EGC).
  • [MeSH-major] Gastric Mucosa / pathology. Gastroscopy. Stomach Neoplasms / pathology
  • [MeSH-minor] Adenocarcinoma / pathology. Aged. Carcinoma / pathology. Female. Gastrectomy. Humans. Male. Neoplasm Invasiveness. Stomach Ulcer / pathology

  • MedlinePlus Health Information. consumer health - Stomach Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16172173.001).
  • [ISSN] 0368-2811
  • [Journal-full-title] Japanese journal of clinical oncology
  • [ISO-abbreviation] Jpn. J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Japan
  •  go-up   go-down


94. Al-Refaie WB, Tseng JF, Gay G, Patel-Parekh L, Mansfield PF, Pisters PW, Yao JC, Feig BW: The impact of ethnicity on the presentation and prognosis of patients with gastric adenocarcinoma. Results from the National Cancer Data Base. Cancer; 2008 Aug 1;113(3):461-9
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] The impact of ethnicity on the presentation and prognosis of patients with gastric adenocarcinoma. Results from the National Cancer Data Base.
  • BACKGROUND: Regional-based studies have indicated that ethnicity is associated with presentation and outcome in patients with gastric adenocarcinoma.
  • To validate this observation in a large cohort, the authors of this report used the National Cancer Data Base (NCDB) to determine whether self-reported ethnicity influences presentation and survival in this patient population.
  • RESULTS: Between 1995 and 2002, 81,095 cases of gastric adenocarcinoma were entered into the NCDB.
  • CONCLUSIONS: Ethnicity was associated with differences in presentation and outcome of patients with gastric adenocarcinoma.
  • [MeSH-major] Adenocarcinoma / diagnosis. Adenocarcinoma / ethnology. Databases, Factual. Stomach Neoplasms / diagnosis. Stomach Neoplasms / ethnology
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Female. Humans. Male. Middle Aged. National Cancer Institute (U.S.). Neoplasm Staging. Prognosis. Survival Analysis. United States

  • MedlinePlus Health Information. consumer health - Stomach Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] (c) 2008 American Cancer Society
  • (PMID = 18553367.001).
  • [ISSN] 0008-543X
  • [Journal-full-title] Cancer
  • [ISO-abbreviation] Cancer
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


95. De Pas T, Sbanotto A, Catania C, Banfi MG, Curigliano G, Nolè F, Fazio N, Formica V, Veronesi G, de Braud F: Oral administration of vinorelbine can overcome intractable endovenous-vinorelbine-associated acute tumor pain. Support Care Cancer; 2005 Mar;13(3):194-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [MeSH-minor] Acute Disease. Adenocarcinoma / complications. Adenocarcinoma / diagnosis. Adenocarcinoma / therapy. Administration, Oral. Aged. Carcinoma, Non-Small-Cell Lung / complications. Carcinoma, Non-Small-Cell Lung / diagnosis. Carcinoma, Non-Small-Cell Lung / therapy. Dose-Response Relationship, Drug. Drug Administration Schedule. Follow-Up Studies. Humans. Infusions, Intravenous. Lung Neoplasms / complications. Lung Neoplasms / diagnosis. Lung Neoplasms / therapy. Male. Middle Aged. Pain Measurement. Severity of Illness Index. Stomach Neoplasms / complications. Stomach Neoplasms / diagnosis. Stomach Neoplasms / therapy

  • Hazardous Substances Data Bank. VINORELBINE .
  • Hazardous Substances Data Bank. VINBLASTINE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Am J Clin Oncol. 2001 Aug;24(4):414-5 [11474276.001]
  • [Cites] Tumori. 1995 May-Jun;81(3):194-6 [7571027.001]
  • [Cites] Eur J Cancer. 1994;30A(6):889 [7917555.001]
  • [Cites] J Natl Cancer Inst. 1996 Nov 6;88(21):1593 [8901858.001]
  • (PMID = 15761704.001).
  • [ISSN] 0941-4355
  • [Journal-full-title] Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
  • [ISO-abbreviation] Support Care Cancer
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Germany
  • [Chemical-registry-number] 5V9KLZ54CY / Vinblastine; Q6C979R91Y / vinorelbine
  •  go-up   go-down


96. Nimura H, Mitsumori N, Takahashi N, Kashimura H, Takayama S, Kashiwagi H, Yanaga K: [S-1 combined with lentinan in patients with unresectable or recurrent gastric cancer]. Gan To Kagaku Ryoho; 2006 Jun;33 Suppl 1:106-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [S-1 combined with lentinan in patients with unresectable or recurrent gastric cancer].
  • Lentinan (LNT) is a beta-glucan known to have a life-prolonging effect in combination with chemotherapy for patients with unresectable or recurrent gastric cancer.
  • Thus, a multi-center trial of chemo-immunotherapy using S-1 combined with LNT may benefit patients with unresectable or recurrent gastric cancer with acceptable toxicity.
  • S-1+LNT regimen may prolong NC periods in patients with unresectable or recurrent gastric cancer.
  • [MeSH-major] Adenocarcinoma / drug therapy. Antineoplastic Combined Chemotherapy Protocols / therapeutic use. Stomach Neoplasms / drug therapy

  • MedlinePlus Health Information. consumer health - Stomach Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16897983.001).
  • [ISSN] 0385-0684
  • [Journal-full-title] Gan to kagaku ryoho. Cancer & chemotherapy
  • [ISO-abbreviation] Gan To Kagaku Ryoho
  • [Language] jpn
  • [Publication-type] Clinical Trial; English Abstract; Journal Article; Multicenter Study
  • [Publication-country] Japan
  • [Chemical-registry-number] 0 / Drug Combinations; 150863-82-4 / S 1 (combination); 1548R74NSZ / Tegafur; 37339-90-5 / Lentinan; 5VT6420TIG / Oxonic Acid
  •  go-up   go-down


97. Pesko P: [Detection of free cancer cells in peritoneal cavity in patients surgically treated for gastric adenocarcinoma]. Vojnosanit Pregl; 2006 Apr;63(4):347-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Detection of free cancer cells in peritoneal cavity in patients surgically treated for gastric adenocarcinoma].
  • [MeSH-major] Adenocarcinoma / surgery. Neoplasm Seeding. Neoplastic Cells, Circulating. Peritoneal Cavity / cytology. Stomach Neoplasms / surgery

  • MedlinePlus Health Information. consumer health - Stomach Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentOn] Vojnosanit Pregl. 2006 Apr;63(4):349-56 [16683401.001]
  • (PMID = 16683400.001).
  • [ISSN] 0042-8450
  • [Journal-full-title] Vojnosanitetski pregled
  • [ISO-abbreviation] Vojnosanit Pregl
  • [Language] srp
  • [Publication-type] Comment; Editorial
  • [Publication-country] Serbia and Montenegro
  •  go-up   go-down


98. Lee JH, Ryu KW, Lee JH, Park SR, Kim CG, Kook MC, Nam BH, Kim YW, Bae JM: Learning curve for total gastrectomy with D2 lymph node dissection: cumulative sum analysis for qualified surgery. Ann Surg Oncol; 2006 Sep;13(9):1175-81
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND: This study was conducted to evaluate the leaning curve of D2 lymph node dissection for patients with gastric cancer in a high-volume center.
  • In clinical trials containing gastric cancer surgery, the learning curve for qualified surgery from the standpoint of oncological outcome should be considered to minimize bias due to surgeon-associated factors.
  • [MeSH-major] Clinical Competence. Gastrectomy. General Surgery / education. Lymph Node Excision. Stomach Neoplasms / surgery
  • [MeSH-minor] Adenocarcinoma / surgery. Adult. Aged. Aged, 80 and over. Female. Humans. Lymphatic Metastasis. Male. Middle Aged. Neoplasm Staging. Physician's Role. Prognosis. Prospective Studies. Survival Rate

  • MedlinePlus Health Information. consumer health - Stomach Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16947008.001).
  • [ISSN] 1068-9265
  • [Journal-full-title] Annals of surgical oncology
  • [ISO-abbreviation] Ann. Surg. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


99. Pai MR, Mathai AM, Kumar S, Prabhu S: Coexistent gastric primary choriocarcinoma and adenocarcinoma. Indian J Pathol Microbiol; 2009 Oct-Dec;52(4):537-9
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Coexistent gastric primary choriocarcinoma and adenocarcinoma.
  • Nongestational and extragonadal disease, especially in the stomach is extremely rare with a poorer prognosis and early metastasis.
  • We herein describe a case of primary gastric choriocarcinoma with liver metastasis in a 69-year-old male.
  • Both endoscopic and radiographic imaging revealed an ulcerated and necrotic circumferential tumor in the pyloric antrum of the stomach.
  • A strongly positive immunohistochemical staining for beta- subunit of human chorionic gonadotropin (beta-HCG) in the choriocarcinomatous component and a proper correlation with elevated serum beta-HCG levels confirmed the diagnosis.
  • [MeSH-major] Adenocarcinoma / complications. Adenocarcinoma / diagnosis. Choriocarcinoma / complications. Choriocarcinoma / diagnosis. Stomach Neoplasms / diagnosis. Stomach Neoplasms / pathology

  • Genetic Alliance. consumer health - Choriocarcinoma.
  • MedlinePlus Health Information. consumer health - Stomach Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19805966.001).
  • [ISSN] 0974-5130
  • [Journal-full-title] Indian journal of pathology & microbiology
  • [ISO-abbreviation] Indian J Pathol Microbiol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] India
  • [Chemical-registry-number] 0 / Chorionic Gonadotropin, beta Subunit, Human
  •  go-up   go-down


100. Makeeva TK, Galkin AA: [Nutritional support in the treatment of gastric cancer]. Vopr Onkol; 2009;55(2):237-40
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Nutritional support in the treatment of gastric cancer].
  • The investigation involved 307 patients operated on for gastric adenocarcinoma.
  • [MeSH-major] Adenocarcinoma / diet therapy. Nutritional Support. Stomach Neoplasms / diet therapy

  • MedlinePlus Health Information. consumer health - Nutritional Support.
  • MedlinePlus Health Information. consumer health - Stomach Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19514383.001).
  • [ISSN] 0507-3758
  • [Journal-full-title] Voprosy onkologii
  • [ISO-abbreviation] Vopr Onkol
  • [Language] rus
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Russia (Federation)
  • [Chemical-registry-number] 0 / Serum Albumin
  •  go-up   go-down






Advertisement